Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Venous Thrombosis

  Free Subscription


Articles published in Thromb Res

Retrieve available abstracts of 450 articles:
HTML format



Single Articles


    July 2021
  1. GRANOT Y, Rozenbaum Z, Ziv-Baran T, Fares R, et al
    Correlation between CT-derived cardiac chamber volume, myocardial injury and mortality in acute pulmonary embolism.
    Thromb Res. 2021;205:63-69.
    PubMed     Abstract available


  2. DANIELSBACKA JS, Rostberg L, Olsen MF, Mannerkorpi K, et al
    "Whole life changed" - Experiences of how symptoms derived from acute pulmonary embolism affects life. A qualitative interview study.
    Thromb Res. 2021;205:56-62.
    PubMed     Abstract available


  3. LACHANT D, Roto D, Rappaport S, Prasad P, et al
    Venous thromboembolism associates with SARS-CoV-2 more than seasonal influenza.
    Thromb Res. 2021;205:40-43.
    PubMed    


  4. METRA B, Summer R, Brooks SE, George G, et al
    Racial disparities in COVID-19 associated pulmonary embolism: A multicenter cohort study.
    Thromb Res. 2021;205:84-91.
    PubMed     Abstract available


  5. GAWLITZA J, Ziegelmayer S, Wilkens H, Jagoda P, et al
    Beyond the d-dimer - Machine-learning assisted pre-test probability evaluation in patients with suspected pulmonary embolism and elevated d-dimers.
    Thromb Res. 2021;205:11-16.
    PubMed     Abstract available


  6. RIGATELLI G, Zuin M
    Not all patent foramen ovales are alike!
    Thromb Res. 2021;203:81.
    PubMed    


  7. SKILLE H, Paulsen B, Hveem K, Severinsen MT, et al
    Prothrombotic genotypes and risk of venous thromboembolism in occult cancer.
    Thromb Res. 2021;205:17-23.
    PubMed     Abstract available


    June 2021
  8. JIN MC, Sussman ES, Feng AY, Han SS, et al
    Hemorrhage risk of direct oral anticoagulants in real-world venous thromboembolism patients.
    Thromb Res. 2021;204:126-133.
    PubMed     Abstract available


  9. RIVERA-LEBRON B, Bauersachs R
    Direct oral anticoagulants for the treatment of pulmonary embolism in patients with renal impairment.
    Thromb Res. 2021;204:101-107.
    PubMed     Abstract available


  10. KO D, Preis SR, Johnson AD, Vasan RS, et al
    Relations of arterial stiffness and endothelial dysfunction with incident venous thromboembolism.
    Thromb Res. 2021;204:108-113.
    PubMed     Abstract available


  11. SANSILVESTRI-MOREL P, Rupin A, Schaffner AP, Bertin F, et al
    S62798, a potent TAFIa inhibitor, accelerates endogenous fibrinolysis in a murine model of pulmonary thromboembolism.
    Thromb Res. 2021;204:81-87.
    PubMed     Abstract available


  12. YAMASHITA Y, Bikdeli B, Monreal M, Morimoto T, et al
    Difference between Japanese and White patients with acute pulmonary embolism.
    Thromb Res. 2021;204:52-56.
    PubMed    


  13. BAN L, Abdul Sultan A, West J, Tata LJ, et al
    External validation of a model to predict women most at risk of postpartum venous thromboembolism: Maternity clot risk.
    Thromb Res. 2021 Jun 8. pii: S0049-3848(21)00360.
    PubMed     Abstract available


  14. BLONDON M, Martinez de Tejada B, Glauser F, Righini M, et al
    Management of high-risk pulmonary embolism in pregnancy.
    Thromb Res. 2021;204:57-65.
    PubMed     Abstract available


  15. MENDONCA JC, Martins J, Fernandes C, Carvalho C, et al
    Cancer risk after a venous thrombotic event - RIETE score.
    Thromb Res. 2021;202:43-44.
    PubMed    


  16. VALERIO L, Corsi G, Granziera S, Holm K, et al
    Sex differences in Lemierre syndrome: Individual patient-level analysis.
    Thromb Res. 2021;202:36-39.
    PubMed    


    May 2021
  17. RAHBAR E, Cotton BA, Wade CE, Cardenas JC, et al
    Acquired antithrombin deficiency is a risk factor for venous thromboembolism after major trauma.
    Thromb Res. 2021;204:9-12.
    PubMed     Abstract available


  18. PAGENHARDT J, Hayward I, Dilcher B, Quedado K, et al
    Incidence of abnormal uterine bleeding in a multicenter implementation study using apixaban and rivaroxaban to treat venous thromboembolism.
    Thromb Res. 2021;204:29-31.
    PubMed    


  19. LE MAO R, Tromeur C, Couturaud F
    A case of acute pulmonary embolism with severe haemoptysis.
    Thromb Res. 2021 May 18. pii: S0049-3848(21)00332.
    PubMed     Abstract available


  20. NOUMEGNI SR, Hoffmann C, Tromeur C, Lacut K, et al
    Frequency and incidence of arterial events in patients with venous thromboembolism compared to the general population: A systematic review and meta-analysis of cohort studies.
    Thromb Res. 2021;203:172-185.
    PubMed     Abstract available


  21. GOTO S, Turpie AGG, Farjat AE, Weitz JI, et al
    The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE.
    Thromb Res. 2021;203:155-162.
    PubMed     Abstract available


  22. BARATH B, Bogati R, Miklos T, Kallai J, et al
    Effect of alpha2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism.
    Thromb Res. 2021;203:110-116.
    PubMed     Abstract available


  23. ARRIBALZAGA K, Martinez-Alfonzo I, Diaz-Aizpun C, Gutierrez-Jomarron I, et al
    Incidence and clinical profile of venous thromboembolism in hospitalized COVID-19 patients from Madrid region.
    Thromb Res. 2021;203:93-100.
    PubMed     Abstract available


  24. JOHNSON SA, Signor EA, Lappe KL, Shi J, et al
    A comparison of natural language processing to ICD-10 codes for identification and characterization of pulmonary embolism.
    Thromb Res. 2021;203:190-195.
    PubMed     Abstract available


  25. MUMOLI N, Conte G, Cei M, Vitale J, et al
    In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis.
    Thromb Res. 2021;203:82-84.
    PubMed    


  26. BAKKUM MJ, Schouten VL, Smulders YM, Nossent EJ, et al
    Accelerated treatment with rtPA for pulmonary embolism induced circulatory arrest.
    Thromb Res. 2021;203:74-80.
    PubMed     Abstract available


  27. HAMER HM, Stroobants AK, Bavalia R, Ponjee GAE, et al
    Diagnostic accuracy of four different D-dimer assays: A post-hoc analysis of the YEARS study.
    Thromb Res. 2021;201:18-22.
    PubMed     Abstract available


    April 2021
  28. BAUMANN KREUZIGER L, Gaddh M, Onadeko O, George G, et al
    Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study.
    Thromb Res. 2021;202:155-161.
    PubMed     Abstract available


  29. KAPTEIN FHJ, Kroft LJM, Hammerschlag G, Ninaber MK, et al
    Pulmonary infarction in acute pulmonary embolism.
    Thromb Res. 2021;202:162-169.
    PubMed     Abstract available


  30. HUSSER D, Hohenstein S, Pellissier V, Konig S, et al
    Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic.
    Thromb Res. 2021;202:145-147.
    PubMed    


    March 2021
  31. DOUROS A, Filliter C, Azoulay L, Tagalakis V, et al
    Effectiveness and safety of direct oral anticoagulants in patients with cancer associated venous thromboembolism.
    Thromb Res. 2021;202:128-133.
    PubMed     Abstract available


  32. YUAN S, Bruzelius M, Hakansson N, Akesson A, et al
    Lifestyle factors and venous thromboembolism in two cohort studies.
    Thromb Res. 2021;202:119-124.
    PubMed     Abstract available


  33. BRAILOVSKY Y, Masic D, Allen S, Lakhter V, et al
    Novel CT-derived parameter is associated with low cardiac index in acute pulmonary embolism.
    Thromb Res. 2021;202:105-107.
    PubMed    


  34. SKEITH L, Le Gal G, Rodger MA
    Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?
    Thromb Res. 2021;202:134-138.
    PubMed     Abstract available


  35. KIRCHBERGER I, Berghaus TM, von Scheidt W, Linseisen J, et al
    COVID-19 risk perceptions, worries and preventive behaviors in patients with previous pulmonary embolism.
    Thromb Res. 2021;202:77-83.
    PubMed     Abstract available


  36. ALLEN S, Chan L, Masic D, Porcaro K, et al
    Comparison of outcomes in catheter-directed versus ultrasound-assisted thrombolysis for management of submassive pulmonary embolism.
    Thromb Res. 2021;202:96-99.
    PubMed    


  37. PETRELLI F, Solinas C
    Reply to the letter to the editor 'Reply to Solinas et al, venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review' by Frere et al.
    Thromb Res. 2021 Mar 11. pii: S0049-3848(21)00092.
    PubMed    


  38. AKTAA S, Wu J, Nadarajah R, Rashid M, et al
    Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study.
    Thromb Res. 2021;202:17-23.
    PubMed     Abstract available


  39. LACUT K, Le Moigne E, Couturaud F, Font C, et al
    Outcomes in patients with acute pulmonary embolism and patent foramen ovale: Findings from the RIETE registry.
    Thromb Res. 2021;202:59-66.
    PubMed     Abstract available


  40. ARANDA C, Peralta L, Gagliardi L, Lopez A, et al
    A significant decrease in D-dimer concentration within one month of anticoagulation therapy as a predictor of both complete recanalization and risk of recurrence after initial pulmonary embolism.
    Thromb Res. 2021;202:31-35.
    PubMed     Abstract available


  41. FRERE C, Ederhy S, Salem JE
    Letter to the editors-in-chief reply to: Solinas et al. Venous and arterial thromboembolic events with immune check point inhibitors: A systematic review.
    Thromb Res. 2021 Mar 3. pii: S0049-3848(21)00083.
    PubMed    


  42. WANG L, Wei S, Zhou B, Wu S, et al
    A nomogram model to predict the venous thromboembolism risk after surgery in patients with gynecological tumors.
    Thromb Res. 2021;202:52-58.
    PubMed     Abstract available


  43. KAPTEIN FHJ, Stals MAM, Grootenboers M, Braken SJE, et al
    Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave.
    Thromb Res. 2021;199:143-148.
    PubMed     Abstract available


  44. ESENWA C, Unda SR, Altschul DJ, Patel NK, et al
    The effect of race on composite thrombotic events in patients with COVID-19.
    Thromb Res. 2021;199:10-13.
    PubMed     Abstract available


    February 2021
  45. WHYTE MB, Barker R, Kelly PA, Gonzalez E, et al
    Three-month follow-up of pulmonary embolism in patients with COVID-19.
    Thromb Res. 2021;201:113-115.
    PubMed    


  46. GARCIA-ORTEGA A, Lopez-Reyes R, Anguera G, Oscullo G, et al
    Venous thromboembolism in solid-organ transplant recipients: Findings from the RIETE registry.
    Thromb Res. 2021;201:131-138.
    PubMed     Abstract available


  47. ANGCHAISUKSIRI P, Goto S, Farjat AE, Fryk H, et al
    Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE.
    Thromb Res. 2021;201:63-72.
    PubMed     Abstract available


  48. JERVAN O, Gleditsch J, Tavoly M, Klok FA, et al
    Pulmonary and cardiac variables associated with persistent dyspnea after pulmonary embolism.
    Thromb Res. 2021;201:90-99.
    PubMed     Abstract available


  49. SKAJAA N, Nagy D, Schonfeldt Troelsen F, Kormendine Farkas D, et al
    Venous thromboembolism and risk of cancer in users of statins: A Danish population-based cohort study.
    Thromb Res. 2021;201:1-5.
    PubMed     Abstract available


  50. MCFARLANE SQ, Patel JP, Auyeung V, Arya R, et al
    An international survey of low molecular weight heparin prescribing in the context of antenatal venous thromboembolism.
    Thromb Res. 2021;200:99-101.
    PubMed    



  51. Early effects of unfractionated heparin on clinical and radiological signs and D-dimer levels in patients with COVID-19 associated pulmonary embolism: An observational cohort study.
    Thromb Res. 2021;200:130-132.
    PubMed    


    January 2021
  52. STEIN PD, Matta F, Hughes PG, Gerstner BJ, et al
    Usefulness of ancillary findings on CT pulmonary angiograms that are negative for pulmonary embolism.
    Thromb Res. 2021;200:48-50.
    PubMed    


  53. BECATTINI C, Cimini LA, Carrier M
    Challenging anticoagulation cases: A case of pulmonary embolism shortly after spontaneous brain bleeding.
    Thromb Res. 2021;200:41-47.
    PubMed     Abstract available


  54. BOIETTI B, Fili S, Peuchot V, Tabares A, et al
    Impact of the use of rivaroxaban in the length of stay of patients treated for acute venous thromboembolism in a developing country.
    Thromb Res. 2021 Jan 26. pii: S0049-3848(21)00030.
    PubMed    


  55. PETERSEN PB, Lindberg-Larsen M, Jorgensen CC, Kehlet H, et al
    Venous thromboembolism after fast-track elective revision hip and knee arthroplasty - A multicentre cohort study of 2814 unselected consecutive procedures.
    Thromb Res. 2021;199:101-105.
    PubMed     Abstract available


  56. GANGARAJU R, Gahagan A, Bhatia S, Kenzik K, et al
    Venous-thromboembolism in elderly patients with acute myeloid leukemia.
    Thromb Res. 2021;200:9-11.
    PubMed    


  57. DESANCHO M, Munn JE, Billett HH, Cheng D, et al
    Transition of care for pediatric and adult patients with venous thromboembolism: A National Quality Improvement Project from the American Thrombosis and Hemostasis Network (ATHN).
    Thromb Res. 2021;200:23-29.
    PubMed     Abstract available


  58. DE WINTER MA, van Es N, Buller HR, Visseren FLJ, et al
    Prediction models for recurrence and bleeding in patients with venous thromboembolism: A systematic review and critical appraisal.
    Thromb Res. 2021;199:85-96.
    PubMed     Abstract available


  59. MURGIER M, Fouillet L, Ollier E, Merah A, et al
    Recovery from acute kidney injury in patients with pulmonary embolism: A single-center study.
    Thromb Res. 2021;199:106-109.
    PubMed    


  60. SINDET-PEDERSEN C, Olesen JB, Blanche P, Gerds TA, et al
    Effect of government interventions to contain the COVID-19 pandemic on incidence of pulmonary embolism - A Danish nationwide register-based cohort study.
    Thromb Res. 2021;199:97-100.
    PubMed    


  61. AYELE HT, Brunetti VC, Renoux C, Tagalakis V, et al
    Testosterone replacement therapy and the risk of venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials.
    Thromb Res. 2021;199:123-131.
    PubMed     Abstract available


  62. MOIK F, Makatsariya A, Ay C
    Challenging anticoagulation cases: Cancer-associated venous thromboembolism and chemotherapy-induced thrombocytopenia - A case-based review of clinical management.
    Thromb Res. 2021;199:38-42.
    PubMed     Abstract available


  63. MANDAL AKJ, Kho J, Ioannou A, Van den Abbeele K, et al
    In situ immune-mediated pulmonary artery thrombosis and Covid-19 pneumonitis.
    Thromb Res. 2021;197:112-113.
    PubMed    


  64. PANCANI R, Villari L, Foci V, Parri G, et al
    Lower limb deep vein thrombosis in COVID-19 patients admitted to intermediate care respiratory units.
    Thromb Res. 2021;197:44-47.
    PubMed     Abstract available


    December 2020
  65. ACHEBE I, Mbachi C, Palacios P, Wang Y, et al
    Predictors of venous thromboembolism in hospitalized patients with inflammatory bowel disease and colon cancer: A retrospective cohort study.
    Thromb Res. 2020;199:14-18.
    PubMed     Abstract available


  66. ALAM AU, Karkhaneh M, Sun HL, Wu C, et al
    Survival patterns among venous thromboembolism patients with hematologic malignancies in Alberta, Canada from 2003 to 2015.
    Thromb Res. 2020;199:59-66.
    PubMed     Abstract available


  67. NAUKA PC, Baron SW, Assa A, Mohrmann L, et al
    Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors.
    Thromb Res. 2020;199:82-84.
    PubMed    


  68. VAN DAM LF, Kroft LJM, Boon GJAM, Huisman MV, et al
    Computed tomography pulmonary perfusion imaging and 3-months clinical outcomes after acute pulmonary embolism.
    Thromb Res. 2020;199:32-34.
    PubMed    


  69. RASHIDI F, Barco S, Kamangar F, Heresi GA, et al
    Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study.
    Thromb Res. 2020;198:135-138.
    PubMed     Abstract available


  70. GUO JD, Hlavacek P, Rosenblatt L, Keshishian A, et al
    Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population.
    Thromb Res. 2020;198:163-170.
    PubMed     Abstract available


  71. DE WIT K, Linkins LA
    A case of acute pulmonary embolism in a patient with chronic thrombocytopenia.
    Thromb Res. 2020;198:83-85.
    PubMed     Abstract available


  72. MIAO R, Dong X, Gong J, Wang Y, et al
    Possible immune regulation mechanisms for the progression of chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2020;198:122-131.
    PubMed     Abstract available


  73. ALHOUSANI M, Malik SU, Abu-Hashyeh A, Poznanski NJ, et al
    Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
    Thromb Res. 2020;198:103-114.
    PubMed     Abstract available


  74. WANG L, Chen F, Bai L, Yi Q, et al
    In situ pulmonary thrombosis in patients with COVID-19 pneumonia: different phenotypes may exist.
    Thromb Res. 2020;196:541-542.
    PubMed    


  75. PARKS AL, Auerbach AD, Schnipper JL, Anstey JE, et al
    COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.
    Thromb Res. 2020;196:355-358.
    PubMed     Abstract available


    November 2020
  76. KANEDA K, Yamashita Y, Morimoto T, Amano H, et al
    Influence of low body weight on long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE registry.
    Thromb Res. 2020;198:26-33.
    PubMed     Abstract available


  77. LI A, Eshaghpour A, Tseng EK, Douketis JD, et al
    Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more.
    Thromb Res. 2020;198:1-6.
    PubMed     Abstract available


  78. POLI D, Migliaccio L, Antonucci E, Biancone L, et al
    Venous thromboembolism in renal transplant recipients: Results of Venous thromboEmbolism in renal Transplant Recipients- Italian Study - VETRIS.
    Thromb Res. 2020;198:52-54.
    PubMed    


  79. SCUDIERO F, Silverio A, Di Maio M, Russo V, et al
    Pulmonary embolism in COVID-19 patients: Prevalence, predictors and clinical outcome.
    Thromb Res. 2020;198:34-39.
    PubMed     Abstract available


  80. STEINBRECHER O, Sinkovec H, Eischer L, Kyrle PA, et al
    D-dimer levels over time after anticoagulation and the association with recurrent venous thromboembolism.
    Thromb Res. 2020;197:160-164.
    PubMed     Abstract available


  81. BUDD AC, Rhodes M, Forster AJ, Noghani P, et al
    Prescribing patterns and outcomes of venous thromboembolism prophylaxis in hospitalized medical and cancer patients: Observations from the Ottawa Hospital.
    Thromb Res. 2020;197:144-152.
    PubMed     Abstract available


  82. PLANQUETTE B, Le Berre A, Khider L, Yannoutsos A, et al
    Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control study.
    Thromb Res. 2020;197:94-99.
    PubMed     Abstract available


  83. ROBERGE G, Delluc A
    Challenging anticoagulation cases: A case of incidental subsegmental pulmonary embolism in a patient with cancer.
    Thromb Res. 2020;197:77-83.
    PubMed     Abstract available


  84. ANDRADE I, Mehdipoor G, Le Mao R, Garcia-Sanchez A, et al
    Prognostic significance of computed tomography-assessed right ventricular enlargement in low-risk patients with pulmonary embolism: Systematic review and meta-analysis.
    Thromb Res. 2020;197:48-55.
    PubMed     Abstract available


  85. PAYNE JG, Tagalakis V, Wu C, Lazo-Langner A, et al
    Current estimates of the incidence of acute venous thromboembolic disease in Canada: A meta-analysis.
    Thromb Res. 2020;197:8-12.
    PubMed     Abstract available


  86. MARCHIORI E, Nobre LF, Hochhegger B, Zanetti G, et al
    The reversed halo sign: Considerations in the context of the COVID-19 pandemic.
    Thromb Res. 2020;195:228-230.
    PubMed    


  87. ELIAS A, Schmidt J, Bellou A, Le Gal G, et al
    Opinion and practice survey about the use of prognostic models in acute pulmonary embolism.
    Thromb Res. 2020;198:40-48.
    PubMed     Abstract available


    October 2020
  88. SERRAO A, Ballotta L, Dragoni F, Pallotta A, et al
    Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants (DOACs) in patients with major congenital thrombophilia.
    Thromb Res. 2020;196:539-540.
    PubMed    


  89. SPEED V, Patel JP, Roberts LN, Patel RK, et al
    UK real-world experience of prescribing rivaroxaban for acute venous thromboembolism in obesity: Results from the FIRST Registry.
    Thromb Res. 2020;197:16-19.
    PubMed    


  90. BRUGGEMANN RAG, Spaetgens B, Gietema HA, Brouns SHA, et al
    The prevalence of pulmonary embolism in patients with COVID-19 and respiratory decline: A three-setting comparison.
    Thromb Res. 2020;196:486-490.
    PubMed     Abstract available


  91. TRUJILLO-SANTOS J, Beroiz P, Moustafa F, Alonso A, et al
    Corrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165].
    Thromb Res. 2020 Oct 13. pii: S0049-3848(20)30537.
    PubMed    


  92. VAN DAM LF, Kroft LJM, van der Wal LI, Cannegieter SC, et al
    More on clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism.
    Thromb Res. 2020;196:435-436.
    PubMed    


  93. HAN X, Li C, Zhang S, Hou X, et al
    Why thromboembolism occurs in some patients with thrombocytopenia and treatment strategies.
    Thromb Res. 2020;196:500-509.
    PubMed     Abstract available


  94. VALERIO L, Corsi G, Sebastian T, Barco S, et al
    Lemierre syndrome: Current evidence and rationale of the Bacteria-Associated Thrombosis, Thrombophlebitis and LEmierre syndrome (BATTLE) registry.
    Thromb Res. 2020;196:494-499.
    PubMed     Abstract available


  95. CHOPARD R, Badoz M, Eveno C, Ecarnot F, et al
    Early prescription of direct oral anticoagulant for the treatment of intermediate-high risk pulmonary embolism: a multi-center, observational cohort study.
    Thromb Res. 2020;196:476-482.
    PubMed     Abstract available


  96. GERSTEIN L, Koolian M, Schwartz BC
    Sub-segmental pulmonary emboli as a marker of CT-pulmonary angiogram overuse in a single-center retrospective cohort study: A dimer a dozen?
    Thromb Res. 2020;196:463-465.
    PubMed    


  97. DOYLE AJ, Thomas W, Retter A, Besser M, et al
    Updated hospital associated venous thromboembolism outcomes with 90-days follow-up after hospitalisation for severe COVID-19 in two UK critical care units.
    Thromb Res. 2020;196:454-456.
    PubMed    


  98. SOLINAS C, Saba L, Sganzerla P, Petrelli F, et al
    Venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review.
    Thromb Res. 2020;196:444-453.
    PubMed     Abstract available


  99. RASMUSSEN PV, Blanche P, Strange JE, Butt JH, et al
    Thromboembolic events related to atrial fibrillation during the COVID-19 epidemic in Denmark.
    Thromb Res. 2020;194:220-221.
    PubMed    


    September 2020
  100. YANG M, Qi J, Tang Y, Wu D, et al
    Increased D-dimer predicts the risk of cancer-associated recurrent venous thromboembolism and venous thromboembolism: A systematic review and meta-analysis.
    Thromb Res. 2020;196:410-413.
    PubMed    


  101. MA SG, Hu J, Huang Y
    The risk factors for perioperative venous thromboembolism in patients with gynecological malignancies: A meta-analysis.
    Thromb Res. 2020;196:325-334.
    PubMed     Abstract available


  102. CHOI JJ, Wehmeyer GT, Li HA, Alshak MN, et al
    D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19.
    Thromb Res. 2020;196:318-321.
    PubMed    


  103. CASTELLON RUBIO VE, Segura PP, Munoz A, Farre AL, et al
    High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score.
    Thromb Res. 2020;196:349-354.
    PubMed     Abstract available


  104. DUJARDIN RWG, Hilderink BN, Haksteen WE, Middeldorp S, et al
    Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
    Thromb Res. 2020;196:308-312.
    PubMed     Abstract available


  105. ROLVING N, Bloch-Nielsen JR, Brocki BC, Andreasen J, et al
    Perspectives of patients and health professionals on important factors influencing rehabilitation following acute pulmonary embolism: A multi-method study.
    Thromb Res. 2020;196:283-290.
    PubMed     Abstract available


  106. PAVONI V, Gianesello L, Pazzi M, Stera C, et al
    Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.
    Thromb Res. 2020;196:313-317.
    PubMed     Abstract available


  107. AGNELLI G, Hoffmann U, Hainaut P, Gaine S, et al
    ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months.
    Thromb Res. 2020;196:297-304.
    PubMed     Abstract available


  108. DELATE T, Charlu M, Zhu S, Pai A, et al
    Temporal trends in first-line outpatient anticoagulation treatment for cancer-associated venous thromboembolism.
    Thromb Res. 2020;196:367-370.
    PubMed     Abstract available


  109. MIRO O, Llorens P, Aguirre A, Lozano L, et al
    Association between Covid-19 and Pulmonary Embolism (AC-19-PE study).
    Thromb Res. 2020;196:322-324.
    PubMed    


  110. PIZZI R, Gini G, Caiano L, Castelli B, et al
    Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency.
    Thromb Res. 2020;196:209-212.
    PubMed     Abstract available


  111. RAJENDRAM R, Kharal GA, Mahmood N, Kharal M, et al
    Systemic thromboemboli in patients with Covid-19 may result from paradoxical embolization.
    Thromb Res. 2020;196:206-208.
    PubMed     Abstract available


    August 2020
  112. HANNEVIK TL, Brekke J, Enden T, Froen H, et al
    Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism.
    Thromb Res. 2020;196:238-244.
    PubMed     Abstract available


  113. BEENEN LFM, Bos LD, Scheerder MJ, Lobe NHJ, et al
    Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia.
    Thromb Res. 2020;196:135-137.
    PubMed    


  114. ZERMATTEN MG, Pantet O, Gomez F, Schneider A, et al
    Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19.
    Thromb Res. 2020;196:222-226.
    PubMed    


  115. SCHAEFER JK, Henke PK, Barnes GD
    Managing suspected venous thromboembolism when a pandemic limits diagnostic testing.
    Thromb Res. 2020;196:213-214.
    PubMed    


  116. COELHO J, Divernet-Queriaud M, Roy PM, Penaloza A, et al
    Comparison of the Wells score and the revised Geneva score as a tool to predict pulmonary embolism in outpatients over age 65.
    Thromb Res. 2020;196:120-126.
    PubMed     Abstract available


  117. JARVIS KB, Nielsen RL, Gupta R, Hede FD, et al
    Polygenic risk score-analysis of thromboembolism in patients with acute lymphoblastic leukemia.
    Thromb Res. 2020;196:15-20.
    PubMed     Abstract available


  118. PORFIDIA A, Valeriani E, Pola R, Porreca E, et al
    Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis.
    Thromb Res. 2020;196:67-74.
    PubMed     Abstract available


  119. KUNUTSOR SK, Laukkanen JA
    Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis.
    Thromb Res. 2020;196:27-30.
    PubMed    


  120. FRIBERG L, Svennberg E
    A diagnosis of atrial fibrillation is not a predictor for pulmonary embolism.
    Thromb Res. 2020;195:238-242.
    PubMed     Abstract available


  121. NOJIMA J, Kaneshige R, Motoki Y, Ieko M, et al
    Increased oxidative stress may be a risk factor for thromboembolic complications in patients with antiphospholipid syndrome.
    Thromb Res. 2020;196:52-53.
    PubMed    


  122. TSOLAKI V, Zakynthinos GE, Mantzarlis K
    Right ventricular dilation: The additive effect of mechanical ventilation on pulmonary embolism in Covid-19 patients.
    Thromb Res. 2020;196:25-26.
    PubMed    


    July 2020
  123. KOVACS MR, Lazo-Langner A, Louzada ML, Kovacs MJ, et al
    Thrombophilia testing in patients receiving rivaroxaban or apixaban for the treatment of venous thromboembolism.
    Thromb Res. 2020;195:231-232.
    PubMed    


  124. HASSAN S, Fanola C, Beckman A, Li F, et al
    Adult Langerhans histiocytosis with rare BRAF mutation complicated by massive pulmonary embolism.
    Thromb Res. 2020;193:207-210.
    PubMed    


  125. ALBERTSEN IE, Nielsen PB
    How to optimize the value of administrative venous thromboembolism codes.
    Thromb Res. 2020;194:195-196.
    PubMed    


  126. NITHIANANDAN H, Reilly A, Tritschler T, Wells P, et al
    Applying rigorous eligibility criteria to studies evaluating prognostic utility of serum biomarkers in pulmonary embolism: A systematic review and meta-analysis.
    Thromb Res. 2020;195:195-208.
    PubMed     Abstract available


  127. ZUIN M, Barco S, Zuliani G, Roncon L, et al
    Management of high-risk pulmonary embolism in an "unstable medical environment": Not only a matter of hemodynamic.
    Thromb Res. 2020;195:193-194.
    PubMed    


  128. TRIMAILLE A, Curtiaud A, Marchandot B, Matsushita K, et al
    Venous thromboembolism in non-critically ill patients with COVID-19 infection.
    Thromb Res. 2020;193:166-169.
    PubMed    


  129. PIAZZA G
    A fortune teller's dream or clinician's nightmare: Right ventricular assessment for risk prediction in pulmonary embolism.
    Thromb Res. 2020;195:169-170.
    PubMed    


  130. EICHINGER S, Lin M, Shi M, Grosso MA, et al
    Recurrent venous thromboembolism during anticoagulation with edoxaban or warfarin: A post hoc analysis of the Hokusai-VTE trial.
    Thromb Res. 2020;195:209-214.
    PubMed     Abstract available


  131. LECUMBERRI R, Ruiz-Artacho P, Trujillo-Santos J, Brenner B, et al
    Management and outcomes of cancer patients with venous thromboembolism presenting with thrombocytopenia.
    Thromb Res. 2020;195:139-145.
    PubMed     Abstract available


  132. WHYTE MB, Kelly PA, Gonzalez E, Arya R, et al
    Pulmonary embolism in hospitalised patients with COVID-19.
    Thromb Res. 2020;195:95-99.
    PubMed     Abstract available


  133. GHANIMA W, Brodin E, Schultze A, Shepherd L, et al
    Incidence and prevalence of venous thromboembolism in Norway 2010-2017.
    Thromb Res. 2020;195:165-168.
    PubMed    


  134. ANDREW L, Ni Ainle F, Blondon M, Rodger MA, et al
    Preventing postpartum venous thromboembolism: A call to action to reduce undue maternal morbidity and mortality.
    Thromb Res. 2020;193:190-197.
    PubMed     Abstract available


  135. PETERSEN PB, Jorgensen CC, Gromov K, Kehlet H, et al
    Venous thromboembolism after fast-track unicompartmental knee arthroplasty - A prospective multicentre cohort study of 3927 procedures.
    Thromb Res. 2020;195:81-86.
    PubMed     Abstract available


  136. SCHWAB-DAUGHERTY EM, Peng MR, Caraccio EE, Stevens SM, et al
    Timing of parenteral anticoagulation after thrombolysis for the treatment of pulmonary embolism.
    Thromb Res. 2020;195:58-61.
    PubMed    


  137. YURIDITSKY E, Mitchell OJL, Sista AK, Xia Y, et al
    Right ventricular stroke distance predicts death and clinical deterioration in patients with pulmonary embolism.
    Thromb Res. 2020;195:29-34.
    PubMed     Abstract available


  138. KLOK FA, Kruip MJHA, van der Meer NJM, Arbous MS, et al
    Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.
    Thromb Res. 2020;191:148-150.
    PubMed     Abstract available


  139. KLOK FA, Kruip MJHA, van der Meer NJM, Arbous MS, et al
    Incidence of thrombotic complications in critically ill ICU patients with COVID-19.
    Thromb Res. 2020;191:145-147.
    PubMed     Abstract available


  140. MARAVEYAS A
    Latest advances in preventing thromboembolic disease in the ambulatory oncology patient.
    Thromb Res. 2020;191 Suppl 1:S91-S98.
    PubMed     Abstract available


  141. SANFILIPPO KM
    Assessing the risk of venous thromboembolism in multiple myeloma.
    Thromb Res. 2020;191 Suppl 1:S74-S78.
    PubMed     Abstract available


  142. GEROTZIAFAS GT, Mahe I, Lefkou E, AboElnazar E, et al
    Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer.
    Thromb Res. 2020;191 Suppl 1:S50-S57.
    PubMed     Abstract available


  143. ILICH A, Kumar V, Henderson M, Mallick R, et al
    Biomarkers in cancer patients at risk for venous thromboembolism: data from the AVERT study.
    Thromb Res. 2020;191 Suppl 1:S31-S36.
    PubMed     Abstract available


  144. NOBLE S
    Venous thromboembolism in palliative care patients: what do we know?
    Thromb Res. 2020;191 Suppl 1:S128-S132.
    PubMed     Abstract available


  145. VERSO M, Agnelli G
    Treatment of venous thromboembolism in patients with cancer: from clinical trials to real life.
    Thromb Res. 2020;191 Suppl 1:S123-S127.
    PubMed     Abstract available


    June 2020
  146. PREVITALI G, Seghezzi M, Moioli V, Sonzogni A, et al
    The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome?
    Thromb Res. 2020;194:192-194.
    PubMed    


  147. NICHETTI F, Russo GL, Prelaj A, Provenzano L, et al
    ALK/ROS1 rearrangements: A real hallmark for thromboembolic events in cancer patients?
    Thromb Res. 2020;194:176-177.
    PubMed    


  148. ZHANG GC, Zhang YY, Zeng QZ, Meng XY, et al
    Outcomes of symptomatic venous thromboembolism after haploidentical donor hematopoietic stem cell transplantation and comparison with human leukocyte antigen-identical sibling transplantation.
    Thromb Res. 2020;194:168-175.
    PubMed     Abstract available


  149. TRUJILLO-SANTOS J, Beroiz P, Moustafa F, Alonso A, et al
    Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism.
    Thromb Res. 2020;193:160-165.
    PubMed     Abstract available


  150. ROBIN P, van Es N, Le Roux PY, Rondina M, et al
    Performance of (18)F-fluorodesoxyglucose positron-emission tomography/computed tomography for cancer screening in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysis.
    Thromb Res. 2020;194:153-157.
    PubMed     Abstract available


  151. MAKHOUL T, Kelly G, Kersten B, Nadler M, et al
    Incidence of thromboembolic events following administration of four-factor prothrombin complex concentrate (4F-PCC) for oral anticoagulation reversal.
    Thromb Res. 2020;194:158-164.
    PubMed     Abstract available


  152. OVERSTAD S, Tjonnfjord E, Garabet L, Fronas S, et al
    Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases.
    Thromb Res. 2020;194:116-118.
    PubMed    


  153. HAYKAL T, Zayed Y, Deliwala S, Kerbage J, et al
    Direct oral anticoagulant versus low-molecular-weight heparin for treatment of venous thromboembolism in cancer patients: An updated meta-analysis of randomized controlled trials.
    Thromb Res. 2020;194:57-65.
    PubMed     Abstract available


  154. DEL-TORO-CERVERA J, Demelo-Rodriguez P, Galeano-Valle F, Fidalgo A, et al
    Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in patients with venous thromboembolism treated with vitamin K antagonists: Findings from the RIETE registry.
    Thromb Res. 2020;194:178-182.
    PubMed     Abstract available


  155. VAN DAM LF, Kroft LJM, van der Wal LI, Cannegieter SC, et al
    Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: A different phenotype of thrombotic disease?
    Thromb Res. 2020;193:86-89.
    PubMed     Abstract available


  156. MURTHY SK, Robertson McCurdy AB, Carrier M, McCurdy JD, et al
    Venous thromboembolic events in inflammatory bowel diseases: A review of current evidence and guidance on risk in the post-hospitalization setting.
    Thromb Res. 2020;194:26-32.
    PubMed     Abstract available


  157. PICART G, Robin P, Tromeur C, Orione C, et al
    Predictors of residual pulmonary vascular obstruction after pulmonary embolism: Results from a prospective cohort study.
    Thromb Res. 2020;194:1-7.
    PubMed     Abstract available


  158. IBRAHIM-KOSTA M, Bailly P, Silvy M, Saut N, et al
    ABO blood group, glycosyltransferase activity and risk of venous thromboembolism.
    Thromb Res. 2020;193:31-35.
    PubMed     Abstract available


  159. VELASCO D, Jimenez D, Bikdeli B, Muriel A, et al
    Outcome of patients with acute symptomatic pulmonary embolism and psychiatric disorders.
    Thromb Res. 2020;193:90-97.
    PubMed     Abstract available


    May 2020
  160. HENDRIKS SV, Bavalia R, van Bemmel T, Bistervels IM, et al
    Current practice patterns of outpatient management of acute pulmonary embolism: A post-hoc analysis of the YEARS study.
    Thromb Res. 2020;193:60-65.
    PubMed     Abstract available


  161. DESBOROUGH MJR, Doyle AJ, Griffiths A, Retter A, et al
    Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom.
    Thromb Res. 2020;193:1-4.
    PubMed    


  162. PACKARD A, Delate T, Martinez K, Clark NP, et al
    Adherence to and persistence with direct oral anticoagulant therapy among patients with new onset venous thromboembolism receiving extended anticoagulant therapy and followed by a centralized anticoagulation service.
    Thromb Res. 2020;193:40-44.
    PubMed     Abstract available


  163. CHEN X, Shao X, Zhang Y, Zhang Z, et al
    Assessment of the Bova score for risk stratification of acute normotensive pulmonary embolism: A systematic review and meta-analysis.
    Thromb Res. 2020;193:99-106.
    PubMed     Abstract available


  164. KONIECZYNSKA M, Kupis RW, Bijak P, Malinowski KP, et al
    Acceptance of a potential major bleeding among patients with venous thromboembolism on long-term oral anticoagulation: the knowledge of the disease and therapy matters.
    Thromb Res. 2020;193:116-121.
    PubMed     Abstract available


  165. AKEL T, Qaqa F, Abuarqoub A, Shamoon F, et al
    Pulmonary embolism: A complication of COVID 19 infection.
    Thromb Res. 2020;193:79-82.
    PubMed     Abstract available


  166. PARRY AH, Wani AH
    Pulmonary embolism in coronavirus disease-19 (COVID-19) and use of compression ultrasonography in its optimal management.
    Thromb Res. 2020 May 16. pii: S0049-3848(20)30194.
    PubMed    


  167. GALEANO-VALLE F, Oblitas CM, Ferreiro-Mazon MM, Alonso-Munoz J, et al
    Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism.
    Thromb Res. 2020 May 15. pii: S0049-3848(20)30189.
    PubMed     Abstract available


  168. RAHMANI J, Haghighian Roudsari A, Bawadi H, Thompson J, et al
    Relationship between body mass index, risk of venous thromboembolism and pulmonary embolism: A systematic review and dose-response meta-analysis of cohort studies among four million participants.
    Thromb Res. 2020;192:64-72.
    PubMed     Abstract available


  169. ROSEN RJ
    Early thromboembolic events in hospitalized COVID-19 patients.
    Thromb Res. 2020;192:1.
    PubMed    


  170. VITALI C, Minniti A, Caporali R, Del Papa N, et al
    Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19.
    Thromb Res. 2020;192:21-22.
    PubMed    


  171. NISHIMOTO Y, Yamashita Y, Morimoto T, Saga S, et al
    Predictive ability of modified Ottawa score for recurrence in patients with cancer-associated venous thromboembolism: From the COMMAND VTE Registry.
    Thromb Res. 2020;191:66-75.
    PubMed     Abstract available


  172. BRUGGEMANN R, Gietema H, Jallah B, Ten Cate H, et al
    Arterial and venous thromboembolic disease in a patient with COVID-19: A case report.
    Thromb Res. 2020 May 1. pii: S0049-3848(20)30163.
    PubMed    


    April 2020
  173. BOUNAMEAUX H, Haas S, Farjat AE, Ageno W, et al
    Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE.
    Thromb Res. 2020;191:103-112.
    PubMed     Abstract available


  174. LODIGIANI C, Iapichino G, Carenzo L, Cecconi M, et al
    Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.
    Thromb Res. 2020;191:9-14.
    PubMed     Abstract available


  175. ELLIS-KAHANA J, Sparks AD, Gimovsky AC, James AH, et al
    Developing a model for predicting venous thromboembolism in obese pregnant women in a national study.
    Thromb Res. 2020;191:42-49.
    PubMed     Abstract available


  176. JOHNSEN HS, Bjori E, Hindberg K, Braekkan SK, et al
    Prothrombotic genotypes and risk of major bleeding in patients with incident venous thromboembolism.
    Thromb Res. 2020;191:82-89.
    PubMed     Abstract available


  177. RONCON L, Zuin M, Zonzin P
    Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in COVID-19 patients.
    Thromb Res. 2020;190:102.
    PubMed    


  178. MARTINELLI I, Ferrazzi E, Ciavarella A, Erra R, et al
    Pulmonary embolism in a young pregnant woman with COVID-19.
    Thromb Res. 2020;191:36-37.
    PubMed    


  179. FANG Q, Du W, Zhang X, Chen D, et al
    Venous thromboembolism and postoperative bleeding in thyroid surgery patients.
    Thromb Res. 2020;190:99-101.
    PubMed    


  180. ROTZINGER DC, Beigelman-Aubry C, von Garnier C, Qanadli SD, et al
    Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography.
    Thromb Res. 2020;190:58-59.
    PubMed     Abstract available


    March 2020
  181. BOON GJAM, Barco S, Bertoletti L, Ghanima W, et al
    Measuring functional limitations after venous thromboembolism: Optimization of the Post-VTE Functional Status (PVFS) Scale.
    Thromb Res. 2020;190:45-51.
    PubMed     Abstract available


  182. KELLER K, Hobohm L, Barco S, Schmidtmann I, et al
    Venous thromboembolism in patients hospitalized for hip joint replacement surgery.
    Thromb Res. 2020;190:1-7.
    PubMed     Abstract available


  183. CHOI SH, Cha SI, Park JE, Park S, et al
    Electrocardiographic changes as a prognostic tool for hospitalized patients with pulmonary embolism.
    Thromb Res. 2020;192:61-63.
    PubMed    


  184. RENZI M, Stafoggia M, Michelozzi P, Davoli M, et al
    Short-term exposure to PM2.5 and risk of venous thromboembolism: A case-crossover study.
    Thromb Res. 2020;190:52-57.
    PubMed     Abstract available


  185. MULDER FI, van Es N, Kraaijpoel N, Di Nisio M, et al
    Corrigendum to "Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study" [Thromb. Res. vol. 185, January 2020, pages 13-19].
    Thromb Res. 2020 Mar 6. pii: S0049-3848(20)30069.
    PubMed    


  186. HASAN RA, Koh AY, Zia A
    The gut microbiome and thromboembolism.
    Thromb Res. 2020;189:77-87.
    PubMed     Abstract available


  187. BAUMGARTNER C, Go AS, Fan D, Sung SH, et al
    Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study.
    Thromb Res. 2020;189:112-118.
    PubMed     Abstract available


  188. LIANG S, Tang W, Ye S, Xiang L, et al
    Incidence and risk factors of preoperative venous thromboembolism and pulmonary embolism in patients with ovarian cancer.
    Thromb Res. 2020;190:129-134.
    PubMed     Abstract available


    February 2020
  189. DEGUCHI TK, Deguchi H, Guo Z, Elias DJ, et al
    Plasma skeletal muscle myosin phenotypes identified by immunoblotting are associated with pulmonary embolism occurrence in young adults.
    Thromb Res. 2020;189:88-92.
    PubMed     Abstract available


  190. KUNUTSOR SK, Barrett MC, Whitehouse MR, Blom AW, et al
    Venous thromboembolism following 672,495 primary total shoulder and elbow replacements: Meta-analyses of incidence, temporal trends and potential risk factors.
    Thromb Res. 2020;189:13-23.
    PubMed     Abstract available


  191. BAVIERA M, Barcella L, Vannini T, Colacioppo P, et al
    Treatment of venous thromboembolism in Northern Italy: A population-based study from 2013 to 2018.
    Thromb Res. 2020;188:97-99.
    PubMed    


  192. DANIELSBACKA JS, Hansson PO, Mannerkorpi K, Olsen MF, et al
    Physical activity and respiratory symptoms after pulmonary embolism. A longitudinal observational study.
    Thromb Res. 2020;189:55-60.
    PubMed     Abstract available


  193. FULCHER J, Carrier M
    Thromboembolism prophylaxis during L-asparaginase therapy in acute lymphoblastic leukemia - time to reconsider current approaches?
    Thromb Res. 2020;188:100-102.
    PubMed     Abstract available


  194. SCHMIDT RA, Al Zaki A, Desilet N, Szefer E, et al
    Patient characteristics and long-term outcomes beyond the first 6 months after a diagnosis of cancer-associated venous thromboembolism.
    Thromb Res. 2020;188:106-114.
    PubMed     Abstract available


    January 2020
  195. ROBIN P, Grewal RK, Le Roux PY, Le Gal G, et al
    Interobserver agreement of (18)F-Fluorodeoxyglucose Positron-Emission Tomography combined with low-dose Computed Tomography for occult cancer screening in patients with unprovoked venous thromboembolism.
    Thromb Res. 2020;188:25-27.
    PubMed    


  196. VAN ES J, Cheung YW, van Es N, Klok FA, et al
    Short-term prognosis of breakthrough venous thromboembolism in anticoagulated patients.
    Thromb Res. 2020;187:125-130.
    PubMed     Abstract available


  197. CALAIS C, Mercier G, Meusy A, Le Collen L, et al
    Pulmonary embolism home treatment: What GP want?
    Thromb Res. 2020;187:180-185.
    PubMed     Abstract available


  198. QUAN S, Smith J, Wu C, Koshman SL, et al
    Anticoagulant therapies and outcomes in obese patients with acute venous thromboembolism.
    Thromb Res. 2020;187:56-62.
    PubMed     Abstract available


  199. TSUYUKI Y, Yamashita Y, Morimoto T, Amano H, et al
    Renal dysfunction and long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE Registry.
    Thromb Res. 2020;187:39-47.
    PubMed     Abstract available


  200. GARVEY S, Dudzinski DM, Giordano N, Torrey J, et al
    Pulmonary embolism with clot in transit: An analysis of risk factors and outcomes.
    Thromb Res. 2020;187:139-147.
    PubMed     Abstract available


    December 2019
  201. BIKDELI B, Wang Y, Jimenez D, Ross JS, et al
    Recent trends in use of inferior vena caval filters in US older adults with acute pulmonary embolism.
    Thromb Res. 2019;186:78-79.
    PubMed    


  202. DOU F, Zhang Y, Yi J, Zhu M, et al
    Association of ALK rearrangement and risk of venous thromboembolism in patients with non-small cell lung cancer: A prospective cohort study.
    Thromb Res. 2019;186:36-41.
    PubMed     Abstract available


  203. DZIKOWSKA-DIDUCH O, Kostrubiec M, Kurnicka K, Lichodziejewska B, et al
    "The post-pulmonary syndrome - results of echocardiographic driven follow up after acute pulmonary embolism".
    Thromb Res. 2019;186:30-35.
    PubMed     Abstract available


  204. FRENETTE A, Gershkovich B, Castellucci LA, Patel RV, et al
    Venous thromboembolism prophylaxis in obese, critically-ill patients: A survey of Ottawa region Intensivists.
    Thromb Res. 2019;186:42-44.
    PubMed    


    November 2019
  205. MEDEIROS SK, Emery B, Bhagirath V, Parpia S, et al
    Does cell-free DNA promote coagulation and inhibit fibrinolysis in patients with unprovoked venous thromboembolism?
    Thromb Res. 2019;186:13-19.
    PubMed     Abstract available


  206. CANTOR N, Carrier M, Rodger MA, Veillet-Lemay G, et al
    Predictors of long-term cancer diagnosis after an unprovoked thromboembolic event: A post-hoc analysis of the REVERSE cohort study.
    Thromb Res. 2019;185:132-134.
    PubMed    


  207. GARIANI K, Hugon-Rodin J, Philippe J, Righini M, et al
    Association between polycystic ovary syndrome and venous thromboembolism: A systematic review and meta-analysis.
    Thromb Res. 2019;185:102-108.
    PubMed     Abstract available


  208. BIKDELI B, Carrier MA, Bates SM
    Subsegmental pulmonary embolism: May not be a killer but indicates significant risk.
    Thromb Res. 2019 Nov 19. pii: S0049-3848(19)30504.
    PubMed    


  209. TRUGILHO IA, Renni MJP, Medeiros GC, Thuler LCS, et al
    Incidence and factors associated with venous thromboembolism in women with gynecologic cancer.
    Thromb Res. 2019;185:49-54.
    PubMed     Abstract available


  210. SIMONA A, Limacher A, Mean M, Golaz O, et al
    High-sensitive cardiac troponin T as a marker of hemorrhagic complications in elderly patients anticoagulated for non-massive pulmonary embolism.
    Thromb Res. 2019;185:5-12.
    PubMed     Abstract available


  211. MULDER FI, van Es N, Kraaijpoel N, Di Nisio M, et al
    Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study.
    Thromb Res. 2019;185:13-19.
    PubMed     Abstract available


  212. JARVIS KB, LeBlanc M, Tulstrup M, Nielsen RL, et al
    Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia - A NOPHO ALL2008 study.
    Thromb Res. 2019;184:92-98.
    PubMed     Abstract available


  213. SKAJAA N, Szepligeti SK, Horvath-Puho E, Ghanima W, et al
    Initiation of statins and risk of venous thromboembolism: Population-based matched cohort study.
    Thromb Res. 2019;184:99-104.
    PubMed     Abstract available


  214. HENDRIKS SV, Huisman MV, Eikenboom JCJ, Fogteloo J, et al
    Home treatment of patients with cancer-associated venous thromboembolism - An evaluation of daily practice.
    Thromb Res. 2019;184:122-128.
    PubMed     Abstract available


  215. YAMASHITA Y, Murata K, Morimoto T, Amano H, et al
    Clinical outcomes of patients with pulmonary embolism versus deep vein thrombosis: From the COMMAND VTE Registry.
    Thromb Res. 2019;184:50-57.
    PubMed     Abstract available


    October 2019
  216. KRIEG VJ, Hobohm L, Liebetrau C, Guth S, et al
    Risk factors for chronic thromboembolic pulmonary hypertension - Importance of thyroid disease and function.
    Thromb Res. 2019;185:20-26.
    PubMed     Abstract available


  217. BONNEFOY PB, Margelidon-Cozzolino V, Catella-Chatron J, Ayoub E, et al
    What's next after the clot? Residual pulmonary vascular obstruction after pulmonary embolism: From imaging finding to clinical consequences.
    Thromb Res. 2019;184:67-76.
    PubMed     Abstract available


  218. STOLLER N, Limacher A, Mean M, Baumgartner C, et al
    Clinical presentation and outcomes in elderly patients with symptomatic isolated subsegmental pulmonary embolism.
    Thromb Res. 2019;184:24-30.
    PubMed     Abstract available


  219. HEENKENDA MK, Malmstrom A, Lysiak M, Mudaisi M, et al
    Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma - The predictive significance of B blood group.
    Thromb Res. 2019;183:136-142.
    PubMed     Abstract available


  220. DE WINTER MA, Remme GCP, Kaasjager KHAH, Nijkeuter M, et al
    Short-term versus extended anticoagulant treatment for unprovoked venous thromboembolism: A survey on guideline adherence and physicians' considerations.
    Thromb Res. 2019;183:49-55.
    PubMed     Abstract available


  221. YU J, Li A, Laureano M, Crowther M, et al
    Frequency of arterial thromboembolism in populations with malignancies: A systematic review.
    Thromb Res. 2019;184:16-23.
    PubMed     Abstract available


  222. BYUN JM, Hong J, Yoon SS, Koh Y, et al
    Incidence and characteristics of venous thromboembolism in Asian patients with primary central nervous system lymphoma undergoing chemotherapy.
    Thromb Res. 2019;183:131-135.
    PubMed     Abstract available


    September 2019
  223. MONREAL M
    Fatal pulmonary embolism or bleeding in patients with venous thromboembolism: implications of real-life data.
    Thromb Res. 2019;181 Suppl 1:S6-S9.
    PubMed     Abstract available


  224. PORRES-AGUILAR M, Jimenez D
    Risk adapted management of acute pulmonary embolism in women.
    Thromb Res. 2019;181 Suppl 1:S29-S32.
    PubMed     Abstract available


  225. KLOK FA, Barco S
    Optimal management of hormonal contraceptives after an episode of venous thromboembolism.
    Thromb Res. 2019;181 Suppl 1:S1-S5.
    PubMed     Abstract available


    August 2019
  226. POLI D, Antonucci E, Bertu L, Vignini E, et al
    Very elderly patients with venous thromboembolism on oral anticoagulation with VKAs or DOACs: Results from the prospective multicenter START2-Register Study.
    Thromb Res. 2019;183:28-32.
    PubMed     Abstract available


  227. SPYROPOULOS AC, Ashton V, Chen YW, Wu B, et al
    Rivaroxaban versus warfarin treatment among morbidly obese patients with venous thromboembolism: Comparative effectiveness, safety, and costs.
    Thromb Res. 2019;182:159-166.
    PubMed     Abstract available


  228. WOJCIK M, Zareba L, Undas A
    Prothrombotic fibrin clot properties are associated with post-discharge venous thromboembolism in acutely ill medical patients.
    Thromb Res. 2019;182:141-149.
    PubMed     Abstract available


  229. ALMOHAMMED OA, Lai L, Khanfar NM, Bleidt B, et al
    Trends of cancer-associated venous thromboembolism (VTE) in the United States (2005-2014).
    Thromb Res. 2019;182:110-115.
    PubMed     Abstract available


  230. RAJPURKAR M, Williams S, Goldenberg NA, Van Ommen CH, et al
    Results of a multinational survey of diagnostic and management practices of thromboembolic pulmonary embolism in children.
    Thromb Res. 2019;183:98-105.
    PubMed     Abstract available


  231. PAN S, Allahwerdy F, Kim K, Feehan M, et al
    Associations between anticoagulant treatment pathways and self-reported harms in patients recently diagnosed with venous thromboembolism.
    Thromb Res. 2019;182:95-100.
    PubMed     Abstract available


  232. KAHR HS, Christiansen OB, Grove A, Iyer V, et al
    Venous thromboembolism in epithelial ovarian cancer. A prospective cohort study.
    Thromb Res. 2019;181:112-119.
    PubMed     Abstract available


  233. DE WIT K
    Addressing emotional and physical distress after pulmonary embolism.
    Thromb Res. 2019 Aug 1. pii: S0049-3848(19)30318.
    PubMed    


    July 2019
  234. XIANG Q, Zhang HX, Wang Z, Liu ZY, et al
    The predictive value of circulating microRNAs for venous thromboembolism diagnosis: A systematic review and diagnostic meta-analysis.
    Thromb Res. 2019;181:127-134.
    PubMed     Abstract available


  235. TEN CATE V, Koeck T, Panova-Noeva M, Rapp S, et al
    A prospective cohort study to identify and evaluate endotypes of venous thromboembolism: Rationale and design of the Genotyping and Molecular Phenotyping in Venous ThromboEmbolism project (GMP-VTE).
    Thromb Res. 2019;181:84-91.
    PubMed     Abstract available


  236. BARBARAWI M, Zayed Y, Kheiri B, Gakhal I, et al
    The role of anticoagulation in venous thromboembolism primary prophylaxis in patients with malignancy: A systematic review and meta-analysis of randomized controlled trials.
    Thromb Res. 2019;181:36-45.
    PubMed     Abstract available


  237. MULDER FI, Kraaijpoel N, Di Nisio M, Meyer G, et al
    The Ottawa score performs poorly in cancer patients with incidental pulmonary embolism.
    Thromb Res. 2019;181:59-63.
    PubMed     Abstract available


    June 2019
  238. ROLVING N, Brocki BC, Andreasen J
    Coping with everyday life and physical activity in the aftermath of an acute pulmonary embolism: A qualitative study exploring patients' perceptions and coping strategies.
    Thromb Res. 2019 Jun 19. pii: S0049-3848(19)30273.
    PubMed     Abstract available


  239. JONES AE, Feehan M, Fleming R, Johnson SA, et al
    Outcomes associated with a change in clinical practice to alleviate emotional harm related to venous thromboembolism.
    Thromb Res. 2019;180:29-31.
    PubMed    


    May 2019
  240. HOSOKAWA K, Abe K, Tsutsui H
    Use of direct oral anticoagulants prevents increase in pulmonary vascular resistance and incidence of clinical worsening in patients with chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2019;180:43-46.
    PubMed    


  241. FIELD TS
    Recurrent venous thromboembolism after cerebral venous thrombosis: which lower-risk survivors are at risk for recurrence?
    Thromb Res. 2019 May 31. pii: S0049-3848(19)30251.
    PubMed    


  242. GILLESPIE C, Foley S, Rowan M, Ewins K, et al
    The OPTICA study (Optimised Computed Tomography Pulmonary Angiography in Pregnancy Quality and Safety study): Rationale and design of a prospective trial assessing the quality and safety of an optimised CTPA protocol in pregnancy.
    Thromb Res. 2019;177:172-179.
    PubMed     Abstract available


  243. YAMASHITA Y, Morimoto T, Amano H, Takase T, et al
    Deep vein thrombosis in upper extremities: Clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry.
    Thromb Res. 2019;177:1-9.
    PubMed     Abstract available


    April 2019
  244. KELLER K, Rappold L, Gerhold-Ay A, Hobohm L, et al
    Sex-specific differences in pulmonary embolism.
    Thromb Res. 2019;178:173-181.
    PubMed     Abstract available


  245. EKSTRAND C, Linder M, Baricault B, Lafaurie M, et al
    Impact of risk factors on the occurrence of arterial thrombosis and venous thromboembolism in adults with primary immune thrombocytopenia - Results from two nationwide cohorts.
    Thromb Res. 2019;178:124-131.
    PubMed     Abstract available


  246. CRUDEN P, Cushman M, Repp AB
    Hospitalist assessment of venous thromboembolism and bleeding risk: A survey study.
    Thromb Res. 2019;178:155-158.
    PubMed    


  247. MATEOS MK, Trahair TN, Mayoh C, Barbaro PM, et al
    Risk factors for symptomatic venous thromboembolism during therapy for childhood acute lymphoblastic leukemia.
    Thromb Res. 2019;178:132-138.
    PubMed     Abstract available


  248. PIRES GS, Ribeiro DD, Oliveira JAQ, Freitas LC, et al
    Risk factors associated with recurrent venous thromboembolism after a first cerebral venous thrombosis event: A cohort study.
    Thromb Res. 2019;178:85-90.
    PubMed     Abstract available


  249. KLOK FA, Barco S, Siegerink B
    Measuring functional limitations after venous thromboembolism: A call to action.
    Thromb Res. 2019;178:59-62.
    PubMed     Abstract available


    March 2019
  250. AHRARI A, Al-Ani F, Wang YP, Lazo-Langner A, et al
    Treatment of venous thromboembolism in acute leukemia: A systematic review.
    Thromb Res. 2019;178:1-6.
    PubMed     Abstract available


  251. BENINCASA G, Costa D, Infante T, Lucchese R, et al
    Interplay between genetics and epigenetics in modulating the risk of venous thromboembolism: A new challenge for personalized therapy.
    Thromb Res. 2019;177:145-153.
    PubMed     Abstract available


  252. SWAN D, Hitchen S, Klok FA, Thachil J, et al
    The problem of under-diagnosis and over-diagnosis of pulmonary embolism.
    Thromb Res. 2019;177:122-129.
    PubMed     Abstract available


    February 2019
  253. VEDOVATI MC, Giustozzi M, Becattini C
    Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants.
    Thromb Res. 2019;177:33-41.
    PubMed     Abstract available


  254. BJORI E, Johnsen HS, Hansen JB, Braekkan SK, et al
    Hospitalization as a trigger for venous thromboembolism - Results from a population-based case-crossover study.
    Thromb Res. 2019;176:115-119.
    PubMed     Abstract available


  255. XU X, Shi L, Ma X, Su H, et al
    RhoA-Rho associated kinase signaling leads to renin-angiotensin system imbalance and angiotensin converting enzyme 2 has a protective role in acute pulmonary embolism.
    Thromb Res. 2019;176:85-94.
    PubMed     Abstract available


  256. LANGE N, Mean M, Stalder O, Limacher A, et al
    Anticoagulation quality and clinical outcomes in multimorbid elderly patients with acute venous thromboembolism.
    Thromb Res. 2019;177:10-16.
    PubMed     Abstract available


  257. JARA-PALOMARES L, van Es N, Praena-Fernandez JM, Le Gal G, et al
    Relationship between type of unprovoked venous thromboembolism and cancer location: An individual patient data meta-analysis.
    Thromb Res. 2019;176:79-84.
    PubMed     Abstract available


  258. MUNSTER AM, Rasmussen TB, Falstie-Jensen AM, Harboe L, et al
    A changing landscape: Temporal trends in incidence and characteristics of patients hospitalized with venous thromboembolism 2006-2015.
    Thromb Res. 2019;176:46-53.
    PubMed     Abstract available


  259. KREUTZ R, Mantovani LG, Haas S, Monje D, et al
    XALIA-LEA: An observational study of venous thromboembolism treatment with rivaroxaban and standard anticoagulation in the Asia-Pacific, Eastern Europe, the Middle East, Africa and Latin America.
    Thromb Res. 2019;176:125-132.
    PubMed     Abstract available


  260. NITHIANANDAN H, Reilly A, Wells P
    Regarding the necessity of an updated meta-analysis on the prognostic value of serum biomarkers in patients with pulmonary embolism.
    Thromb Res. 2019;176:8-10.
    PubMed    


  261. DAVIS KA, Puleo CR, Kovalic AJ, Nisly SA, et al
    Efficacy and safety of direct oral anticoagulant therapy for the treatment of venous thromboembolism in patients with chronic liver disease.
    Thromb Res. 2019;176:27-29.
    PubMed    


    January 2019
  262. APIPONGRAT D, Numbenjapon T, Prayoonwiwat W, Arnutti P, et al
    Association between SLC44A2 rs2288904 polymorphism and risk of recurrent venous thromboembolism among Thai patients.
    Thromb Res. 2019;174:163-165.
    PubMed    


  263. CHIN-YEE N, Tanuseputro P, Carrier M, Noble S, et al
    Thromboembolic disease in palliative and end-of-life care: A narrative review.
    Thromb Res. 2019;175:84-89.
    PubMed     Abstract available


    December 2018
  264. PESAVENTO R, de Conti G, Motta R, Ceccato D, et al
    Low reproducibility of the diagnosis of subsegmental pulmonary embolism in symptomatic patients.
    Thromb Res. 2018;175:6-7.
    PubMed    


  265. THIYAGARAJAH K, Ellingwood L, Endres K, Hegazi A, et al
    Post-thrombotic syndrome and recurrent thromboembolism in patients with upper extremity deep vein thrombosis: A systematic review and meta-analysis.
    Thromb Res. 2018;174:34-39.
    PubMed     Abstract available


  266. CHOPARD R, Andarelli JN, Humbert S, Falvo N, et al
    Prescription patterns of direct oral anticoagulants in pulmonary embolism: A prospective multicenter French registry.
    Thromb Res. 2018;174:27-33.
    PubMed     Abstract available


  267. WANG X, Tang N, Wang X, Lu Y, et al
    PROS1 IVS10+5G>A mutation causes hereditary protein S deficiency in a Chinese patient with pulmonary embolism and venous thromboembolism.
    Thromb Res. 2018;174:1-4.
    PubMed    


  268. REINER MF, Muller D, Gobbato S, Stalder O, et al
    Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolism.
    Thromb Res. 2018;174:40-47.
    PubMed     Abstract available


  269. WHITE D, Woller SC, Stevens SM, Collingridge DS, et al
    Comparative thrombosis risk of vascular access devices among critically ill medical patients.
    Thromb Res. 2018;172:54-60.
    PubMed     Abstract available


    November 2018
  270. ZUIN M, Rigatelli G, Carraro M, Pastore G, et al
    Systemic thrombolysis in haemodynamically unstable pulmonary embolism: The earlier the better?
    Thromb Res. 2018;173:117-123.
    PubMed     Abstract available


  271. LI M, Guo Q, Hu W
    Incidence, risk factors, and outcomes of venous thromboembolism after oncologic surgery: A systematic review and meta-analysis.
    Thromb Res. 2018;173:48-56.
    PubMed     Abstract available


  272. HAU A, Wegener E, Ignjatovic V, Revel-Vilk S, et al
    Family history of venous thromboembolism in the paediatric population: The need for a standardized definition.
    Thromb Res. 2018;173:91-95.
    PubMed     Abstract available


  273. ZUMBRUNN B, Stalder O, Mean M, Limacher A, et al
    Association between insurance status, anticoagulation quality, and clinical outcomes in patients with acute venous thromboembolism.
    Thromb Res. 2018;173:124-130.
    PubMed     Abstract available



  274. TO TEST OR NOT TO TEST THAT IS THE QUESTION.
    Thromb Res. 2018;171:199.
    PubMed    


    October 2018
  275. HOUGHTON DE, Alsawas M, Barrioneuvo P, Tello M, et al
    Testosterone therapy and venous thromboembolism: A systematic review and meta-analysis.
    Thromb Res. 2018;172:94-103.
    PubMed     Abstract available


  276. HAGAN KA, Harrington LB, Kim J, Lindstrom S, et al
    Adiposity throughout the life course and risk of venous thromboembolism.
    Thromb Res. 2018;172:67-73.
    PubMed     Abstract available


  277. LIN YC, Lee SH, Chen IJ, Chang CH, et al
    Symptomatic pulmonary embolism following hip fracture: A nationwide study.
    Thromb Res. 2018;172:120-127.
    PubMed     Abstract available


    September 2018
  278. BARCO S, Klok FA, Mahe I, Marchena PJ, et al
    Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis.
    Thromb Res. 2018 Sep 27. pii: S0049-3848(18)30547.
    PubMed     Abstract available


  279. BAYAM E, Kalcik M, Gurbuz AS, Yesin M, et al
    The relationship between heparanase levels, thrombus burden and thromboembolism in patients receiving unfractionated heparin treatment for prosthetic valve thrombosis.
    Thromb Res. 2018;171:103-110.
    PubMed     Abstract available


  280. ROBIN P, Otten HM, Delluc A, van Es N, et al
    Effect of occult cancer screening on mortality in patients with unprovoked venous thromboembolism.
    Thromb Res. 2018;171:92-96.
    PubMed     Abstract available


  281. MOUSTAFA F, Stehouwer A, Kamphuisen P, Sahuquillo JC, et al
    Management and outcome of major bleeding in patients receiving vitamin K antagonists for venous thromboembolism.
    Thromb Res. 2018;171:74-80.
    PubMed     Abstract available


  282. TAVOLY M, Wik HS, Sirnes PA, Jelsness-Jorgensen LP, et al
    The impact of post-pulmonary embolism syndrome and its possible determinants.
    Thromb Res. 2018;171:84-91.
    PubMed     Abstract available


  283. VEDOVATI MC, Giustozzi M, Bonitta G, Agnelli G, et al
    Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysis.
    Thromb Res. 2018;170:175-180.
    PubMed     Abstract available


  284. AL RAWAHI B, Almegren M, Carrier M
    The efficacy and safety of anticoagulation in cerebral vein thrombosis: A systematic review and meta-analysis.
    Thromb Res. 2018;169:135-139.
    PubMed     Abstract available


    August 2018
  285. GOYARD C, Cote B, Looten V, Roche A, et al
    Determinants and prognostic implication of diagnostic delay in patients with a first episode of pulmonary embolism.
    Thromb Res. 2018 Aug 26. pii: S0049-3848(18)30475.
    PubMed     Abstract available


  286. TEN CATE H, Lensing AWA, Weitz JI, Middeldorp S, et al
    The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients.
    Thromb Res. 2018;170:75-83.
    PubMed     Abstract available


  287. KUNUTSOR SK, Beswick AD, Whitehouse MR, Blom AW, et al
    Systematic review of risk prediction scores for venous thromboembolism following joint replacement.
    Thromb Res. 2018;168:148-155.
    PubMed     Abstract available


  288. PRANDONI P, Lensing AWA, Prins MH, Gebel M, et al
    Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin.
    Thromb Res. 2018;168:121-129.
    PubMed     Abstract available


    July 2018
  289. CHEUNG KL, Bouchard BA, Cushman M
    Venous thromboembolism, factor VIII and chronic kidney disease.
    Thromb Res. 2018;170:10-19.
    PubMed     Abstract available


  290. PATANWALA AE, Seaman SM, Kopp BJ, Erstad BL, et al
    Heparin dosing for venous thromboembolism prophylaxis in obese hospitalized patients: An observational study.
    Thromb Res. 2018;169:152-156.
    PubMed     Abstract available


  291. RODGER MA, Le Gal G, Langlois NJ, Gin B, et al
    "HERDOO2" clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism. Can I use any d-Dimer?
    Thromb Res. 2018;169:82-86.
    PubMed     Abstract available


  292. LUNDBECH M, Krag AE, Hvas AM
    Prevalence of venous thromboembolism following head and neck cancer surgery: A systematic review and meta-analysis.
    Thromb Res. 2018;169:30-34.
    PubMed    


  293. DI NISIO M, Candeloro M, Rutjes AWS, Galli V, et al
    Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness.
    Thromb Res. 2018;169:44-49.
    PubMed     Abstract available


  294. CHATURVEDI S, Kohli R, Schaefer N, Clancy M, et al
    Characteristics and outcomes of venous thromboembolism in patients with hereditary hemorrhagic telangiectasia.
    Thromb Res. 2018;169:41-43.
    PubMed    


    June 2018
  295. HOILAND II, Liang RA, Hindberg K, Latysheva N, et al
    Associations between complement pathways activity, mannose-binding lectin, and odds of unprovoked venous thromboembolism.
    Thromb Res. 2018;169:50-56.
    PubMed     Abstract available


  296. ROVINSKI D, Ramos RB, Fighera TM, Casanova GK, et al
    Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
    Thromb Res. 2018;168:83-95.
    PubMed     Abstract available


  297. SCAGLIOLA R
    Electrocardiographic changes in pulmonary embolism: Each lead could be a clue in solving the puzzle.
    Thromb Res. 2018;168:78-79.
    PubMed    


  298. CROLES FN, Mulder R, Mulder AB, Lukens MV, et al
    beta-Antithrombin, subtype of antithrombin deficiency and the risk of venous thromboembolism in hereditary antithrombin deficiency: A family cohort study.
    Thromb Res. 2018;168:47-52.
    PubMed     Abstract available


  299. DELLUC A, Clemons M
    Poor outcomes after venous thromboembolism in cancer patients: It's time to change practice.
    Thromb Res. 2018 Jun 2. pii: S0049-3848(18)30377.
    PubMed    


    May 2018
  300. SALIBA W, Warwar A, Kotler A, Cohen S, et al
    Association of factor V activity with risk of venous thromboembolism and atherothrombotic cardiovascular events: A retrospective population-based cohort study.
    Thromb Res. 2018;168:14-19.
    PubMed     Abstract available


  301. COLEMAN CI, Peacock WF, Bunz TJ, Beyer-Westendorf J, et al
    Effectiveness and safety of rivaroxaban versus warfarin in patients with unprovoked venous thromboembolism: A propensity-score weighted administrative claims cohort study.
    Thromb Res. 2018;168:31-36.
    PubMed     Abstract available


  302. MOESKER MJ, Damen NL, Volmeijer EE, Dreesens D, et al
    Guidelines' risk assessment recommendations for venous thromboembolism prophylaxis: A comparison and implementability appraisal.
    Thromb Res. 2018;168:5-13.
    PubMed     Abstract available


  303. KLINE JA, Ellison AM, Kanis J, Pike JW, et al
    Evaluation of the pulmonary embolism rule out criteria (PERC rule) in children evaluated for suspected pulmonary embolism.
    Thromb Res. 2018;168:1-4.
    PubMed     Abstract available


  304. FEEHAN M, Walsh M, Van Duker H, Godin J, et al
    Prevalence and correlates of bleeding and emotional harms in a national US sample of patients with venous thromboembolism: A cross-sectional structural equation model.
    Thromb Res. 2018 May 23. pii: S0049-3848(18)30366.
    PubMed     Abstract available


  305. DRONKERS CEA, Lijfering WM, Teichert M, van der Meer FJM, et al
    Persistence to direct oral anticoagulants for acute venous thromboembolism.
    Thromb Res. 2018;167:135-141.
    PubMed     Abstract available


  306. BURSTEIN B, Barbosa RS, Kalfon E, Joza J, et al
    Pulmonary embolism after electrophysiology procedures: Incidence from a single centre registry.
    Thromb Res. 2018;167:125-127.
    PubMed    


  307. VANNI S, Becattini C, Nazerian P, Bova C, et al
    Early discharge of patients with pulmonary embolism in daily clinical practice: A prospective observational study comparing clinical gestalt and clinical rules.
    Thromb Res. 2018;167:37-43.
    PubMed     Abstract available


  308. YOUNG K, Paz-Ares L, Thatcher N, Spigel DR, et al
    Venous thromboembolism with EGFR monoclonal antibody necitumumab in stage IV non-small cell lung cancer: A retrospective cohort analysis.
    Thromb Res. 2018;167:50-56.
    PubMed     Abstract available


  309. LAZO-LANGNER A, Al-Ani F, Weisz S, Rozanski C, et al
    Prevention of venous thromboembolism in pregnant patients with a history of venous thromboembolic disease: A retrospective cohort study.
    Thromb Res. 2018;167:20-25.
    PubMed     Abstract available


  310. TAKACH LAPNER S, Stevens SM, Woller SC, Snow G, et al
    Age-adjusted versus clinical probability-adjusted D-dimer to exclude pulmonary embolism.
    Thromb Res. 2018;167:15-19.
    PubMed     Abstract available


    April 2018
  311. HUANG D, Chan PH, She HL, Wong CK, et al
    Secular trends and etiologies of venous thromboembolism in Chinese from 2004 to 2016.
    Thromb Res. 2018;166:80-85.
    PubMed     Abstract available


  312. SUN X, Li J, Shi J
    Validating the Chinese version of the PEmb-QoL questionnaire: A measure for quality of life assessment after pulmonary embolism.
    Thromb Res. 2018;166:86-91.
    PubMed     Abstract available


  313. SIRBU IV, Nistor DO, Hutanu A, Banescu C, et al
    Can the electrocardiogram be used for predicting risk in patients with acute pulmonary embolism?
    Thromb Res. 2018;166:76.
    PubMed    


  314. YAMASHITA Y, Morimoto T, Toyota T, Shiomi H, et al
    Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: A systemic review and meta-analysis.
    Thromb Res. 2018;166:37-42.
    PubMed     Abstract available


  315. VAN ES N, Hisada Y, Di Nisio M, Cesarman G, et al
    Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study.
    Thromb Res. 2018;166:54-59.
    PubMed     Abstract available


  316. ARROYO AB, de Los Reyes-Garcia AM, Teruel-Montoya R, Vicente V, et al
    microRNAs in the haemostatic system: More than witnesses of thromboembolic diseases?
    Thromb Res. 2018;166:1-9.
    PubMed     Abstract available


  317. PARRY BA, Chang AM, Schellong SM, House SL, et al
    International, multicenter evaluation of a new D-dimer assay for the exclusion of venous thromboembolism using standard and age-adjusted cut-offs.
    Thromb Res. 2018;166:63-70.
    PubMed     Abstract available


  318. BOVA C, Vanni S, Prandoni P, Morello F, et al
    A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism.
    Thromb Res. 2018;165:107-111.
    PubMed     Abstract available


  319. ROBIN P, Carrier M
    Revisiting occult cancer screening in patients with unprovoked venous thromboembolism.
    Thromb Res. 2018;164 Suppl 1:S7-S11.
    PubMed     Abstract available


  320. LIEBMAN HA
    Cancer prognosis in patients with venous thromboembolism (VTE) and patients with clinical and laboratory biomarkers predictive of VTE risk.
    Thromb Res. 2018;164 Suppl 1:S19-S22.
    PubMed     Abstract available


  321. PIRAN S, Schulman S
    Management of recurrent venous thromboembolism in patients with cancer: A review.
    Thromb Res. 2018;164 Suppl 1:S172-S177.
    PubMed     Abstract available


  322. VERSO M, Franco L, Giustozzi M, Becattini C, et al
    Treatment of venous thromboembolism in patients with cancer: What news from clinical trials?
    Thromb Res. 2018;164 Suppl 1:S168-S171.
    PubMed     Abstract available


  323. KIMPTON M, Wells PS, Carrier M
    Apixaban for the prevention of venous thromboembolism in high-risk ambulatory cancer patients receiving chemotherapy: Rational and design of the AVERT trial.
    Thromb Res. 2018;164 Suppl 1:S124-S129.
    PubMed     Abstract available


  324. GRAN OV, Braekkan SK, Hansen JB
    Prothrombotic genotypes and risk of venous thromboembolism in cancer.
    Thromb Res. 2018;164 Suppl 1:S12-S18.
    PubMed     Abstract available


  325. LYMAN GH, Culakova E, Poniewierski MS, Kuderer NM, et al
    Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer.
    Thromb Res. 2018;164 Suppl 1:S112-S118.
    PubMed     Abstract available


    March 2018
  326. JOHANSSON M, Lind M, Jansson JH, Fharm E, et al
    Fasting plasma glucose, oral glucose tolerance test, and the risk of first-time venous thromboembolism. A report from the VEINS cohort study.
    Thromb Res. 2018;165:86-94.
    PubMed     Abstract available


  327. OEDINGEN C, Scholz S, Razum O
    Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: The role of the progestogen type and estrogen dose.
    Thromb Res. 2018;165:68-78.
    PubMed     Abstract available


  328. THURN L, Wikman A, Lindqvist PG
    Postpartum blood transfusion and hemorrhage as independent risk factors for venous thromboembolism.
    Thromb Res. 2018;165:54-60.
    PubMed     Abstract available


  329. VOILS SA, Shahin MH, Garrett TJ, Frye RF, et al
    Metabolomic association between venous thromboembolism in critically ill trauma patients and kynurenine pathway of tryptophan metabolism.
    Thromb Res. 2018;165:6-13.
    PubMed     Abstract available


  330. LEE YH, Cha SI, Shin KM, Lim JK, et al
    Clinical relevance of syncope in patients with pulmonary embolism.
    Thromb Res. 2018;164:85-89.
    PubMed     Abstract available


  331. PESAVENTO R, Prandoni P
    Prevention and treatment of the chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2018 Mar 2. pii: S0049-3848(18)30264.
    PubMed     Abstract available


  332. PRASCA S, Carmona R, Ji L, Ko RH, et al
    Obesity and risk for venous thromboembolism from contemporary therapy for pediatric acute lymphoblastic leukemia.
    Thromb Res. 2018;165:44-50.
    PubMed     Abstract available


  333. GAL GL, Righini M
    Preface to Diagnosis of venous thromboembolism.
    Thromb Res. 2018;163:200.
    PubMed    


    February 2018
  334. QUEZADA CA, Bikdeli B, Barrios D, Morillo R, et al
    Assessment of coexisting deep vein thrombosis for risk stratification of acute pulmonary embolism.
    Thromb Res. 2018;164:40-44.
    PubMed     Abstract available


  335. BRANCHFORD BR, Betensky M, Goldenberg NA
    Pediatric issues in thrombosis and hemostasis: The how and why of venous thromboembolism risk stratification in hospitalized children.
    Thromb Res. 2018 Feb 17. pii: S0049-3848(18)30072.
    PubMed     Abstract available


  336. WILLICH SN, Chuang LH, van Hout B, Gumbs P, et al
    Pulmonary embolism in Europe - Burden of illness in relationship to healthcare resource utilization and return to work.
    Thromb Res. 2018;170:181-191.
    PubMed     Abstract available


  337. KAHN SR, Pengo V
    Special issue: Late consequences of venous thromboembolism.
    Thromb Res. 2018 Feb 13. pii: S0049-3848(18)30067.
    PubMed    


  338. JAFFRAY J, Rajpurkar M, Sharathkumar A, Patel K, et al
    Transition of care for patients with venous thromboembolism: Rationale, design and implementation of a quality intervention project conducted at American Thrombosis and Hemostasis Network (ATHN) affiliated sites.
    Thromb Res. 2018;163:146-152.
    PubMed     Abstract available


    January 2018
  339. SAMUELSON BANNOW BT, Konkle BA
    Laboratory biomarkers for venous thromboembolism risk in patients with hematologic malignancies: A review.
    Thromb Res. 2018;163:138-145.
    PubMed     Abstract available


  340. COLEMAN CI, Turpie AGG, Bunz TJ, Baker WL, et al
    Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable state.
    Thromb Res. 2018;163:132-137.
    PubMed     Abstract available


  341. RODGER M, Langlois N, Middeldorp S, Kahn S, et al
    Initial strides for invent-VTE: Towards global collaboration to accelerate clinical research in venous thromboembolism.
    Thromb Res. 2018;163:128-131.
    PubMed     Abstract available


  342. CASAZZA F, Pacchetti I, Rulli E, Roncon L, et al
    Prognostic significance of electrocardiogram at presentation in patients with pulmonary embolism of different severity.
    Thromb Res. 2018;163:123-127.
    PubMed     Abstract available


  343. BEYER-WESTENDORF J
    What have we learned from real-world NOAC studies in venous thromboembolism treatment?
    Thromb Res. 2018;163:83-91.
    PubMed     Abstract available


  344. VAN ES N, Louzada M, Carrier M, Tagalakis V, et al
    Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study.
    Thromb Res. 2018;163:41-46.
    PubMed     Abstract available


  345. FERNANDES T, Auger W, Fedullo P
    Epidemiology and risk factors for chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2018 Jan 8. pii: S0049-3848(18)30012.
    PubMed    


  346. SIUDUT J, Natorska J, Zabczyk M, Zajac D, et al
    Impaired plasminogen binding in patients with venous thromboembolism: Association with protein carbonylation.
    Thromb Res. 2018;163:12-18.
    PubMed     Abstract available


  347. KARATHANOS C, Spanos K, Giannoukas A
    Residual pulmonary vascular obstruction as predictor of pulmonary embolism recurrence after a first unprovoked episode.
    Thromb Res. 2018;162:77-78.
    PubMed    


    December 2017
  348. VANASSCHE T, Verhamme P, Wells PS, Segers A, et al
    Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial.
    Thromb Res. 2017;162:7-14.
    PubMed     Abstract available


  349. WAN T, Rodger M, Zeng W, Robin P, et al
    Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study.
    Thromb Res. 2017 Dec 7. pii: S0049-3848(17)30582.
    PubMed     Abstract available


  350. JIMENEZ D, Nieto R, Corres J, Fernandez-Golfin C, et al
    Diclofenac for reversal of right ventricular dysfunction in acute normotensive pulmonary embolism: A pilot study.
    Thromb Res. 2017;162:1-6.
    PubMed     Abstract available


    November 2017
  351. JIMENEZ D, Yusen RD
    Outpatient therapy for acute symptomatic pulmonary embolism diagnosed in the emergency department: Time to improve the evidence base.
    Thromb Res. 2017 Nov 26. pii: S0049-3848(17)30584.
    PubMed    


  352. BACH AG, Taute BM, Surov A
    Time to threshold as a new indicator of circulatory state and prognosis in patients with pulmonary embolism.
    Thromb Res. 2017;161:26-32.
    PubMed     Abstract available


  353. KLIL-DRORI AJ, Coulombe J, Suissa S, Hirsch A, et al
    Temporal trends in outpatient management of incident pulmonary embolism and associated mortality.
    Thromb Res. 2017 Nov 6. pii: S0049-3848(17)30542.
    PubMed     Abstract available


    October 2017
  354. POPOOLA VO, Tavakoli F, Lau BD, Lankiewicz M, et al
    Exploring the impact of route of administration on medication acceptance in hospitalized patients: Implications for venous thromboembolism prevention.
    Thromb Res. 2017;160:109-113.
    PubMed     Abstract available


  355. FALLER N, Stalder O, Limacher A, Bassetti S, et al
    Frequency of use and acceptability of clinical prediction rules for pulmonary embolism among Swiss general internal medicine residents.
    Thromb Res. 2017;160:9-13.
    PubMed     Abstract available


  356. RATTAZZI M, Villalta S, De Lucchi L, Sponchiado A, et al
    Chronic kidney disease is associated with increased risk of venous thromboembolism recurrence.
    Thromb Res. 2017;160:32-37.
    PubMed     Abstract available


  357. ZIA A, Russell J, Sarode R, Veeram SR, et al
    Markers of coagulation activation, inflammation and fibrinolysis as predictors of poor outcomes after pediatric venous thromboembolism: A systematic review and meta-analysis.
    Thromb Res. 2017;160:1-8.
    PubMed     Abstract available


    September 2017
  358. ROBIN P, Le Roux PY, Tromeur C, Planquette B, et al
    Risk factors of occult malignancy in patients with unprovoked venous thromboembolism.
    Thromb Res. 2017;159:48-51.
    PubMed     Abstract available


  359. KRISTOFFERSEN AH, Ajzner E, Bauca JM, Carraro P, et al
    Pre- and post-test probabilities of venous thromboembolism and diagnostic accuracy of D-dimer, estimated by European clinicians working in emergency departments.
    Thromb Res. 2017;159:19-23.
    PubMed    


  360. KHARAT A, Hachulla AL, Noble S, Lador F, et al
    Modern diagnosis of chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2017 Sep 9. pii: S0049-3848(17)30486.
    PubMed     Abstract available


  361. BARRIOS D, Morillo R, Yusen RD, Jimenez D, et al
    Pulmonary embolism severity assessment and prognostication.
    Thromb Res. 2017 Sep 8. pii: S0049-3848(17)30485.
    PubMed     Abstract available


  362. KNIGHT-PERRY J, Branchford BR, Thornhill D, Martiniano SL, et al
    Venous thromboembolism in children with cystic fibrosis: Retrospective incidence and intrapopulation risk factors.
    Thromb Res. 2017;158:161-166.
    PubMed     Abstract available


  363. GADE IL, Braekkan S, Naess IA, Hansen JB, et al
    Epidemiology of venous thromboembolism in hematological cancers: The Scandinavian Thrombosis and Cancer (STAC) cohort.
    Thromb Res. 2017;158:157-160.
    PubMed     Abstract available


  364. CHAN WS
    Diagnosis of venous thromboembolism in pregnancy.
    Thromb Res. 2017 Sep 5. pii: S0049-3848(17)30482.
    PubMed     Abstract available


    August 2017
  365. MEZEI ZA, Katona E, Kallai J, Bereczky Z, et al
    Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism.
    Thromb Res. 2017;158:93-97.
    PubMed     Abstract available


  366. KONIGSBRUGGE O, Lorenz M, Auinger M, Schmaldienst S, et al
    Venous thromboembolism and vascular access thrombosis in patients with end-stage renal disease on maintenance hemodialysis: Cross-sectional results of the Vienna InVestigation of AtriaL fibrillation and thromboembolism in patients on hemoDIalysis (VIV
    Thromb Res. 2017;158:59-64.
    PubMed     Abstract available


  367. EL-REFAI SM, Black EP, Adams VR, Talbert JC, et al
    Statin use and venous thromboembolism in cancer: A large, active comparator, propensity score matched cohort study.
    Thromb Res. 2017;158:49-58.
    PubMed     Abstract available


    July 2017
  368. BAUERSACHS R, Agnelli G, Gitt AK, Monreal M, et al
    The role of heparin lead-in in the real-world management of acute venous thromboembolism: The PREFER in VTE registry.
    Thromb Res. 2017;157:181-188.
    PubMed     Abstract available


  369. DZIKOWSKA-DIDUCH O, Domienik-Karlowicz J, Gorska E, Demkow U, et al
    E-selectin and sICAM-1, biomarkers of endothelial function, predict recurrence of venous thromboembolism.
    Thromb Res. 2017;157:173-180.
    PubMed     Abstract available


  370. GHANIMA W, Wik HS, Tavoly M, Enden T, et al
    Late consequences of venous thromboembolism: Measuring quality of life after deep vein thrombosis and pulmonary embolism.
    Thromb Res. 2017 Jul 23. pii: S0049-3848(17)30434.
    PubMed     Abstract available


  371. ZHOU M, Zhang L, Ding Y, Wang Y, et al
    Extensive screening for occult malignancy in unprovoked venous thromboembolism: A meta-analysis.
    Thromb Res. 2017;157:147-153.
    PubMed     Abstract available


  372. PRANDONI P, Lensing AWA, Prins MH, Noventa F, et al
    Does the presence of clinical symptoms of pulmonary embolism affect the outcome of patients with deep vein thrombosis?
    Thromb Res. 2017;157:134-135.
    PubMed    


    June 2017
  373. LE ROUX PY, Robin P, Salaun PY
    New developments and future challenges of nuclear medicine and molecular imaging for pulmonary embolism.
    Thromb Res. 2017 Jun 27. pii: S0049-3848(17)30394.
    PubMed     Abstract available


  374. ARENDT JFH, Farkas DK, Pedersen L, Sorensen HT, et al
    Elevated plasma vitamin B12 levels and risk of venous thromboembolism among cancer patients: A population-based cohort study.
    Thromb Res. 2017;156:177-183.
    PubMed     Abstract available


  375. WALEN S, Katerberg B, Boomsma MF, van den Berg JWK, et al
    Safety, feasibility and patient reported outcome measures of outpatient treatment of pulmonary embolism.
    Thromb Res. 2017;156:172-176.
    PubMed     Abstract available


  376. WAN T, Skeith L, Karovitch A, Rodger M, et al
    Guidance for the diagnosis of pulmonary embolism during pregnancy: Consensus and controversies.
    Thromb Res. 2017;157:23-28.
    PubMed     Abstract available


  377. HELLMAN T, Kiviniemi T, Nuotio I, Vasankari T, et al
    Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation.
    Thromb Res. 2017;156:163-167.
    PubMed     Abstract available


  378. KRUGER S, Haas M, Burkl C, Goehring P, et al
    Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
    Thromb Res. 2017;157:9-15.
    PubMed     Abstract available


  379. SISTA AK, Klok FA
    Late outcomes of pulmonary embolism: The post-PE syndrome.
    Thromb Res. 2017 Jun 16. pii: S0049-3848(17)30381.
    PubMed     Abstract available


  380. MA Y, Wang Y, Liu D, Ning Z, et al
    A safe strategy to rule out pulmonary embolism: The combination of the Wells score and D-dimer test: One prospective study.
    Thromb Res. 2017;156:160-162.
    PubMed    


  381. SHARMA S, Lang IM
    Current understanding of the pathophysiology of chronic thromboembolic pulmonary hypertension.
    Thromb Res. 2017 Jun 12. pii: S0049-3848(17)30375.
    PubMed     Abstract available


  382. DONADINI MP, Dentali F, Castellaneta M, Gnerre P, et al
    Pulmonary embolism prognostic factors and length of hospital stay: A cohort study.
    Thromb Res. 2017;156:155-159.
    PubMed     Abstract available


  383. MANSOUR S, Alotaibi G, Wu C, McMurtry MS, et al
    Trends in admission rates and in-hospital stay for venous thromboembolism.
    Thromb Res. 2017;156:149-154.
    PubMed     Abstract available


  384. AL MEGREN M, De Wit C, Al Qahtani M, Le Gal G, et al
    Management of venous thromboembolism in patients with glioma.
    Thromb Res. 2017;156:105-108.
    PubMed     Abstract available


  385. KLINE JA
    Diagnosis and Exclusion of Pulmonary Embolism.
    Thromb Res. 2017 Jun 7. pii: S0049-3848(17)30358.
    PubMed     Abstract available


  386. KONSTANTINIDES SV, Barco S
    Prevention of early complications and late consequences after acute pulmonary embolism: Focus on reperfusion techniques.
    Thromb Res. 2017 Jun 1. pii: S0049-3848(17)30352.
    PubMed     Abstract available


  387. HUSSEINZADEH H, Carrier M
    Occult cancer detection in patients with hemostatic disorder and venous thromboembolism.
    Thromb Res. 2017 Jun 1. pii: S0049-3848(17)30354.
    PubMed     Abstract available


    May 2017
  388. LIEDL G, Nazerian P, Pepe G, Caviglioli C, et al
    Different time course of plasma lactate, troponin I and Nt-proBNP concentrations in patients with acute pulmonary embolism.
    Thromb Res. 2017;156:26-28.
    PubMed    


  389. BARCO S, Konstantinides S, Huisman MV, Klok FA, et al
    Diagnosis of recurrent venous thromboembolism.
    Thromb Res. 2017 May 26. pii: S0049-3848(17)30344.
    PubMed     Abstract available


  390. LUONG NV, Kroll MH, Vu K
    Recurrence of venous thromboembolism among adults acute leukemia patients treated at the University of Texas MD Anderson Cancer Center: Incidence and risk factors.
    Thromb Res. 2017;156:14-19.
    PubMed     Abstract available


  391. TRITSCHLER T, Aujesky D
    Venous thromboembolism in the elderly: A narrative review.
    Thromb Res. 2017;155:140-147.
    PubMed     Abstract available


  392. REZANIA S, Puskarich MA, Petrusca DN, Neto-Neves EM, et al
    Platelet hyperactivation, apoptosis and hypercoagulability in patients with acute pulmonary embolism.
    Thromb Res. 2017;155:106-115.
    PubMed     Abstract available


  393. ROY PM, Moumneh T, Penaloza A, Sanchez O, et al
    Outpatient management of pulmonary embolism.
    Thromb Res. 2017;155:92-100.
    PubMed     Abstract available


  394. WASSEF A, Lim W, Wu C
    Indications, complications and outcomes of inferior vena cava filters: A retrospective study.
    Thromb Res. 2017;153:123-128.
    PubMed     Abstract available


    April 2017
  395. ROBIN P, Le Roux PY, Le Moigne E, Planquette B, et al
    Additional testing following screening strategies for occult malignancy diagnosis in patients with unprovoked venous thromboembolism.
    Thromb Res. 2017;155:6-9.
    PubMed     Abstract available


  396. DITTMAR M, Smith N, Warren B, Clark B, et al
    Improved sensitivity and specificity of pediatric hospital-acquired venous thromboembolism case identification by addition of radiographic and pharmacologic elements.
    Thromb Res. 2017;154:93-95.
    PubMed    


  397. LANGE N, Stalder O, Aujesky D
    Is clinical pre-test probability assessment for venous thromboembolism underused?
    Thromb Res. 2017;155:10-11.
    PubMed    


  398. KEVANE B, Ainle FN
    Contraception and menstrual bleeding during venous thromboembolism treatment: Does current practice reflect expert option?
    Thromb Res. 2017 Apr 12. pii: S0049-3848(17)30281.
    PubMed    


  399. CHU JN, Maselli J, Auerbach AD, Fang MC, et al
    The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.
    Thromb Res. 2017;155:65-71.
    PubMed     Abstract available


  400. SQUIZZATO A, Pomero F, Allione A, Priotto R, et al
    Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: A bivariate meta-analysis.
    Thromb Res. 2017;154:64-72.
    PubMed     Abstract available


    March 2017
  401. GON Y, Sakaguchi M, Takasugi J, Mochizuki H, et al
    Ischemic stroke in cancer patients treated with direct oral anticoagulants for venous thromboembolism.
    Thromb Res. 2017;154:16-18.
    PubMed     Abstract available


  402. KLOK FA, Schreiber K, Stach K, Ageno W, et al
    Oral contraception and menstrual bleeding during treatment of venous thromboembolism: Expert opinion versus current practice: Combined results of a systematic review, expert panel opinion and an international survey.
    Thromb Res. 2017;153:101-107.
    PubMed     Abstract available


  403. BRUNSON A, Ho G, White R, Wun T, et al
    Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE) does not improve clinical outcomes: A population-based study.
    Thromb Res. 2017;153:57-64.
    PubMed     Abstract available


  404. BEYAN C, Beyan E
    Mean platelet volume may not be an alternative test instead of platelet aggregation in patients with venous thromboembolism.
    Thromb Res. 2017;153:50.
    PubMed    


  405. MA K, Kahn SR, Hirsch AM, Akaberi A, et al
    N-terminal of prohormone brain natriuretic peptide predicts functional limitation one year following pulmonary embolism: Results from the ELOPE study.
    Thromb Res. 2017;153:47-49.
    PubMed    


  406. RUHLE F, Stoll M
    Genetic factors in pediatric venous thromboembolism.
    Thromb Res. 2017;151 Suppl 1:S97-S99.
    PubMed     Abstract available


  407. BARCO S, Konstantinides SV
    Risk-adapted management of pulmonary embolism.
    Thromb Res. 2017;151 Suppl 1:S92-S96.
    PubMed     Abstract available


  408. TROMEUR C, van der Pol LM, Klok FA, Couturaud F, et al
    Pitfalls in the diagnostic management of pulmonary embolism in pregnancy.
    Thromb Res. 2017;151 Suppl 1:S86-S91.
    PubMed     Abstract available


  409. BLANCO-MOLINA A, Trujillo-Santos J, Pesavento R, Rosa V, et al
    Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use.
    Thromb Res. 2017;151 Suppl 1:S6-S10.
    PubMed     Abstract available


  410. MARTIN-MARTOS F, Trujillo-Santos J, Del Toro J, Bura-Riviere A, et al
    Gender differences in patients with venous thromboembolism and five common sites of cancer.
    Thromb Res. 2017;151 Suppl 1:S16-S20.
    PubMed     Abstract available


  411. TZORAN I, Papadakis E, Brenner B, Valle R, et al
    Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia.
    Thromb Res. 2017;151 Suppl 1:S11-S15.
    PubMed     Abstract available


  412. MOUSTAFA F, Fernandez S, Fernandez-Capitan C, Nieto JA, et al
    Uterine bleeding during anticoagulation in women with venous thromboembolism.
    Thromb Res. 2017;151 Suppl 1:S1-S5.
    PubMed     Abstract available


    February 2017
  413. VAN ES N, Wells PS, Carrier M
    Bleeding risk in patients with unprovoked venous thromboembolism: A critical appraisal of clinical prediction scores.
    Thromb Res. 2017;152:52-60.
    PubMed     Abstract available


  414. WILTS IT, Le Gal G, Den Exter PL, Van Es J, et al
    Performance of the age-adjusted cut-off for D-dimer in patients with cancer and suspected pulmonary embolism.
    Thromb Res. 2017;152:49-51.
    PubMed     Abstract available


  415. THEBERGE I, Bowdridge J, Forgie MA, Carrier M, et al
    Rivaroxaban shows promise as effective therapy for cancer patients with venous thromboembolic disease.
    Thromb Res. 2017;152:4-6.
    PubMed    


  416. NOJIMA J, Motoki Y, Hara K, Sakata T, et al
    Detection of antibodies against domain 1 of beta2-glycoprotein I is key in predicting thromboembolic complications in patients with systemic lupus erythematosus.
    Thromb Res. 2017;153:83-84.
    PubMed    


    January 2017
  417. KHORANA AA, Francis CW, Kuderer NM, Carrier M, et al
    Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial.
    Thromb Res. 2017 Jan 26. pii: S0049-3848(17)30020.
    PubMed     Abstract available


  418. PUURUNEN MK, Hwang SJ, O'Donnell CJ, Tofler G, et al
    Platelet function as a risk factor for venous thromboembolism in the Framingham Heart Study.
    Thromb Res. 2017;151:57-62.
    PubMed     Abstract available


  419. COWAN LT, Lutsey PL, Pankow JS, Cushman M, et al
    Hospitalization with infection and incident venous thromboembolism: The ARIC study.
    Thromb Res. 2017;151:74-78.
    PubMed     Abstract available


  420. COYLE K, Carrier M, Lazo-Langner A, Shivakumar S, et al
    Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism.
    Thromb Res. 2017;151:67-71.
    PubMed     Abstract available


  421. KUO TH, Li HY, Lin SH
    Acute kidney injury and risk of deep vein thrombosis and pulmonary embolism in Taiwan: A nationwide retrospective cohort study.
    Thromb Res. 2017;151:29-35.
    PubMed     Abstract available


  422. ENDE-VERHAAR YM, Huisman MV, Klok FA
    To screen or not to screen for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.
    Thromb Res. 2017;151:1-7.
    PubMed     Abstract available


    December 2016
  423. ZOLLER B, Li X, Ohlsson H, Sundquist J, et al
    Seasonal variation of pulmonary embolism and age dependence.
    Thromb Res. 2016;150:76-77.
    PubMed    


  424. ROSS JA, Miller MM, Rojas Hernandez CM
    Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis.
    Thromb Res. 2016;150:86-89.
    PubMed     Abstract available


  425. VAN ES N, Franke VF, Middeldorp S, Wilmink JW, et al
    The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer.
    Thromb Res. 2016;150:30-32.
    PubMed     Abstract available


  426. SWIER N, Versteeg HH
    Reciprocal links between venous thromboembolism, coagulation factors and ovarian cancer progression.
    Thromb Res. 2016;150:8-18.
    PubMed     Abstract available


  427. OZCAN CETIN EH, Cetin MS, Canpolat U, Akdi A, et al
    Platelet-to-lymphocyte ratio as a novel marker of in-hospital and long-term adverse outcomes among patients with acute pulmonary embolism: A single center large-scale study.
    Thromb Res. 2016;150:33-40.
    PubMed     Abstract available


  428. PIOVELLA F, Iosub DI
    Extended non-vitamin K antagonist oral anticoagulation therapy for prevention of recurrent venous thromboembolism.
    Thromb Res. 2016 Dec 7. pii: S0049-3848(16)30645.
    PubMed     Abstract available


  429. GARCIA-HORTON A, Kovacs MJ, Abdulrehman J, Taylor JE, et al
    Impact of thrombophilia screening on venous thromboembolism management practices.
    Thromb Res. 2016;149:76-80.
    PubMed     Abstract available


    November 2016
  430. OLIE V, Bonaldi C
    Pulmonary embolism: Does the seasonal effect depend on age? A 12-year nationwide analysis of hospitalization and mortality.
    Thromb Res. 2016 Nov 30. pii: S0049-3848(16)30640.
    PubMed     Abstract available


  431. LIN CL, Lin CL, Tzeng SL, Chung WS, et al
    Aplastic anemia and risk of deep vein thrombosis and pulmonary embolism: A nationwide cohort study.
    Thromb Res. 2016;149:70-75.
    PubMed     Abstract available


  432. BURWEN DR, Wu C, Cirillo D, Rossouw JE, et al
    Venous thromboembolism incidence, recurrence, and mortality based on Women's Health Initiative data and Medicare claims.
    Thromb Res. 2016;150:78-85.
    PubMed     Abstract available


    October 2016
  433. PLANQUETTE B, Ferre A, Peron J, Vial-Dupuy A, et al
    Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism. A single center cohort study.
    Thromb Res. 2016;148:70-75.
    PubMed     Abstract available


  434. ALEXANDER M, Burbury K
    A systematic review of biomarkers for the prediction of thromboembolism in lung cancer - Results, practical issues and proposed strategies for future risk prediction models.
    Thromb Res. 2016;148:63-69.
    PubMed     Abstract available


  435. BEYER-WESTENDORF J
    Letter to the Editor "Gender related aspects of bleeding with rivaroxaban in venous thromboembolism - Potential for pitfalls": A comment to "Impact of gender on safety and efficacy of rivaroxaban in adolescents & young adults with venous thromboem
    Thromb Res. 2016 Oct 26. pii: S0049-3848(16)30601.
    PubMed    


  436. ZOLLER B, Ohlsson H, Sundquist J, Sundquist K, et al
    A sibling based design to quantify genetic and shared environmental effects of venous thromboembolism in Sweden.
    Thromb Res. 2016 Oct 20. pii: S0049-3848(16)30587.
    PubMed     Abstract available


  437. KANG J, Lee JS, Lee JH, Lee KM, et al
    Recurrent pulmonary embolism during dabigatran treatment in a patient with immune thrombocytopenic purpura.
    Thromb Res. 2016;148:23-24.
    PubMed    


  438. MELANCON T, Bivona C, Klenke S, Rockey M, et al
    Comparison of postoperative venous thromboembolism incidence in gastrointestinal and gynecologic solid tumors.
    Thromb Res. 2016;147:104-107.
    PubMed     Abstract available


  439. RABINOVICH E, Bartholomew JR, Wilks ML, Tripp BL, et al
    Centralizing care of cancer-associated thromboembolism: The Cleveland Clinic experience.
    Thromb Res. 2016;147:102-103.
    PubMed    


  440. PIRAN S, Schulman S
    Incidence and risk factors for venous thromboembolism in patients with acute spinal cord injury: A retrospective study.
    Thromb Res. 2016;147:97-101.
    PubMed     Abstract available


    September 2016
  441. CORRAINI P, Ording AG, Henderson VW, Szepligeti S, et al
    Cancer, other comorbidity, and risk of venous thromboembolism after stroke: a population-based cohort study.
    Thromb Res. 2016;147:88-93.
    PubMed     Abstract available


  442. VINSON DR, Ballard DW, Mark DG, Huang J, et al
    Risk stratifying emergency department patients with acute pulmonary embolism: Does the simplified Pulmonary Embolism Severity Index perform as well as the original?
    Thromb Res. 2016;148:1-8.
    PubMed     Abstract available


  443. DEMELO-RODRIGUEZ P, Postigo-Esteban A, Garcia-Fernandez-Bravo I, Agud M, et al
    Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in a cohort of patients with venous thromboembolism treated with vitamin K antagonists.
    Thromb Res. 2016;147:58-60.
    PubMed     Abstract available


  444. VOILS SA, Lemon SJ, Jordan J, Riley P, et al
    Early thrombin formation capacity in trauma patients and association with venous thromboembolism.
    Thromb Res. 2016;147:13-15.
    PubMed     Abstract available


  445. BLEKER SM, Beenen LF, Di Nisio M, van Es N, et al
    Incidental pulmonary embolism in cancer patients: Interobserver agreement on the diagnosis and extent with a focus on distal clots.
    Thromb Res. 2016;147:46-51.
    PubMed     Abstract available


  446. ARACHCHILLAGE D, Reynolds R, Devey T, Maclean R, et al
    Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience.
    Thromb Res. 2016;147:32-35.
    PubMed    


  447. KRAUSE M, Henningsen A, Torge A, Juhl D, et al
    Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism.
    Thromb Res. 2016 Sep 13. pii: S0049-3848(16)30542.
    PubMed    


    May 2016
  448. NICKEL KF, Labberton L, Long AT, Langer F, et al
    The polyphosphate/factor XII pathway in cancer-associated thrombosis: novel perspectives for safe anticoagulation in patients with malignancies.
    Thromb Res. 2016;141 Suppl 2:S4-7.
    PubMed     Abstract available


  449. GAUTHIER K, Le Gal G, Shivakumar S, Anderson D, et al
    Inter-observer reliability of the HERDOO2 clinical decision rule.
    Thromb Res. 2016;141:136-8.
    PubMed    


    February 2016
  450. OLIVIER CB, Weik P, Meyer M, Weber S, et al
    TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran.
    Thromb Res. 2016;138:63-8.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Venous Thrombosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: